id	sid	tid	token	lemma	pos
aji-30	1	1	_	_	PUNCT
aji-30	2	1	_	_	PUNCT
aji-30	3	1	_	_	PUNCT
aji-30	4	1	_	_	PUNCT
aji-30	5	1	_	_	PUNCT
aji-30	6	1	_	_	PUNCT
aji-30	7	1	_	_	PUNCT
aji-30	8	1	_	_	PUNCT
aji-30	9	1	_	_	PUNCT
aji-30	10	1	_	_	PUNCT
aji-30	11	1	_	_	PUNCT
aji-30	12	1	_	_	PUNCT
aji-30	13	1	_	_	PUNCT
aji-30	14	1	_	_	PUNCT
aji-30	15	1	_	_	PUNCT
aji-30	16	1	_	_	PUNCT
aji-30	17	1	_	_	PUNCT
aji-30	18	1	_	_	PUNCT
aji-30	19	1	_	_	PUNCT
aji-30	20	1	_	_	PUNCT
aji-30	21	1	_	_	PUNCT
aji-30	22	1	_	_	PUNCT
aji-30	23	1	_	_	PUNCT
aji-30	24	1	_	_	PUNCT
aji-30	25	1	_	_	PUNCT
aji-30	26	1	_	_	PUNCT
aji-30	27	1	_	_	PUNCT
aji-30	28	1	_	_	PUNCT
aji-30	29	1	_	_	PUNCT
aji-30	30	1	_	_	PUNCT
aji-30	31	1	_	_	PUNCT
aji-30	32	1	_	_	PUNCT
aji-30	33	1	_	_	PUNCT
aji-30	34	1	_	_	PUNCT
aji-30	35	1	_	_	PUNCT
aji-30	36	1	_	_	PUNCT
aji-30	37	1	_	_	PUNCT
aji-30	38	1	_	_	PUNCT
aji-30	39	1	_	_	PUNCT
aji-30	40	1	_	_	PUNCT
aji-30	41	1	_	_	PUNCT
aji-30	42	1	_	_	PUNCT
aji-30	43	1	_	_	PUNCT
aji-30	44	1	_	_	PUNCT
aji-30	45	1	_	_	PUNCT
aji-30	46	1	_	_	PUNCT
aji-30	47	1	_	_	PUNCT
aji-30	48	1	_	_	PUNCT
aji-30	49	1	_	_	PUNCT
aji-30	50	1	_	_	PUNCT
aji-30	51	1	_	_	PUNCT
aji-30	52	1	_	_	PUNCT
aji-30	53	1	_	_	PUNCT
aji-30	54	1	_	_	PUNCT
aji-30	55	1	_	_	PUNCT
aji-30	56	1	_	_	PUNCT
aji-30	57	1	_	_	PUNCT
aji-30	58	1	_	_	PUNCT
aji-30	59	1	_	_	PUNCT
aji-30	60	1	_	_	PUNCT
aji-30	61	1	_	_	PUNCT
aji-30	62	1	_	_	PUNCT
aji-30	63	1	_	_	PUNCT
aji-30	64	1	_	_	PUNCT
aji-30	65	1	_	_	PUNCT
aji-30	66	1	_	_	PUNCT
aji-30	67	1	_	_	PUNCT
aji-30	68	1	_	_	PUNCT
aji-30	69	1	_	_	PUNCT
aji-30	70	1	_	_	PUNCT
aji-30	71	1	_	_	PUNCT
aji-30	72	1	_	_	PUNCT
aji-30	73	1	_	_	PUNCT
aji-30	74	1	_	_	PUNCT
aji-30	75	1	_	_	PUNCT
aji-30	76	1	_	_	PUNCT
aji-30	77	1	_	_	PUNCT
aji-30	78	1	_	_	PUNCT
aji-30	79	1	_	_	PUNCT
aji-30	80	1	_	_	PUNCT
aji-30	81	1	_	_	PUNCT
aji-30	82	1	_	_	PUNCT
aji-30	83	1	_	_	PUNCT
aji-30	84	1	_	_	PUNCT
aji-30	85	1	_	_	PUNCT
aji-30	86	1	_	_	PUNCT
aji-30	87	1	_	_	PUNCT
aji-30	88	1	_	_	PUNCT
aji-30	89	1	_	_	PUNCT
aji-30	90	1	_	_	PUNCT
aji-30	91	1	_	_	PUNCT
aji-30	92	1	_	_	PUNCT
aji-30	93	1	_	_	PUNCT
aji-30	94	1	_	_	PUNCT
aji-30	95	1	_	_	PUNCT
aji-30	96	1	_	_	PUNCT
aji-30	97	1	_	_	PUNCT
aji-30	98	1	_	_	PUNCT
aji-30	99	1	_	_	PUNCT
aji-30	100	1	_	_	PUNCT
aji-30	101	1	_	_	PUNCT
aji-30	102	1	*	*	PUNCT
aji-30	102	2	corresponding	correspond	VERB
aji-30	102	3	author	author	NOUN
aji-30	102	4	:	:	PUNCT
aji-30	102	5	e	e	NOUN
aji-30	102	6	-	-	NOUN
aji-30	102	7	mail	mail	NOUN
aji-30	102	8	:	:	PUNCT
aji-30	103	1	mariajnad66@gmail.com	mariajnad66@gmail.com	ADJ
aji-30	103	2	;	;	PUNCT
aji-30	103	3	asian	asian	ADJ
aji-30	103	4	journal	journal	NOUN
aji-30	103	5	of	of	ADP
aji-30	103	6	immunology	immunology	NOUN
aji-30	103	7	3(1	3(1	NUM
aji-30	103	8	):	):	PUNCT
aji-30	103	9	305	305	NUM
aji-30	103	10	-	-	SYM
aji-30	103	11	310	310	NUM
aji-30	103	12	,	,	PUNCT
aji-30	103	13	2020	2020	NUM
aji-30	103	14	;	;	PUNCT
aji-30	103	15	article	article	NOUN
aji-30	103	16	no.aji.61363	no.aji.61363	VERB
aji-30	103	17	the	the	DET
aji-30	103	18	relationship	relationship	NOUN
aji-30	103	19	between	between	ADP
aji-30	103	20	the	the	DET
aji-30	103	21	levels	level	NOUN
aji-30	103	22	of	of	ADP
aji-30	103	23	anti	anti	X
aji-30	103	24	cyclic	cyclic	ADJ
aji-30	103	25	citrullinated	citrullinate	VERB
aji-30	103	26	protein	protein	NOUN
aji-30	103	27	antibodies	antibodie	VERB
aji-30	103	28	type2	type2	PROPN
aji-30	103	29	(	(	PUNCT
aji-30	103	30	acpa2	acpa2	PROPN
aji-30	103	31	)	)	PUNCT
aji-30	103	32	and	and	CCONJ
aji-30	103	33	the	the	DET
aji-30	103	34	severity	severity	NOUN
aji-30	103	35	of	of	ADP
aji-30	103	36	erosive	erosive	ADJ
aji-30	103	37	rheumatoid	rheumatoid	NOUN
aji-30	103	38	arthritis	arthritis	NOUN
aji-30	103	39	(	(	PUNCT
aji-30	103	40	ra	ra	NOUN
aji-30	103	41	)	)	PUNCT
aji-30	103	42	m.	m.	NOUN
aji-30	103	43	jnad1	jnad1	PROPN
aji-30	103	44	*	*	PROPN
aji-30	103	45	,	,	PUNCT
aji-30	103	46	k.	k.	PROPN
aji-30	103	47	aldou1	aldou1	PROPN
aji-30	103	48	and	and	CCONJ
aji-30	103	49	h.	h.	PROPN
aji-30	103	50	yazaji2	yazaji2	PROPN
aji-30	103	51	1	1	NUM
aji-30	103	52	division	division	NOUN
aji-30	103	53	of	of	ADP
aji-30	103	54	rheumatology	rheumatology	NOUN
aji-30	103	55	,	,	PUNCT
aji-30	103	56	department	department	NOUN
aji-30	103	57	of	of	ADP
aji-30	103	58	internal	internal	ADJ
aji-30	103	59	medicine	medicine	NOUN
aji-30	103	60	,	,	PUNCT
aji-30	103	61	tishreen	tishreen	NUM
aji-30	103	62	university	university	NOUN
aji-30	103	63	hospital	hospital	NOUN
aji-30	103	64	,	,	PUNCT
aji-30	103	65	lattakia	lattakia	PROPN
aji-30	103	66	,	,	PUNCT
aji-30	103	67	syria	syria	PROPN
aji-30	103	68	.	.	PROPN
aji-30	104	1	2	2	NUM
aji-30	104	2	department	department	NOUN
aji-30	104	3	of	of	ADP
aji-30	104	4	laboratory	laboratory	NOUN
aji-30	104	5	,	,	PUNCT
aji-30	104	6	tishreen	tishreen	NUM
aji-30	104	7	university	university	NOUN
aji-30	104	8	hospital	hospital	NOUN
aji-30	104	9	,	,	PUNCT
aji-30	104	10	lattakia	lattakia	PROPN
aji-30	104	11	,	,	PUNCT
aji-30	104	12	syria	syria	PROPN
aji-30	104	13	.	.	PUNCT
aji-30	105	1	authors	author	NOUN
aji-30	105	2	’	’	PART
aji-30	105	3	contributions	contribution	NOUN
aji-30	105	4	this	this	DET
aji-30	105	5	work	work	NOUN
aji-30	105	6	was	be	AUX
aji-30	105	7	carried	carry	VERB
aji-30	105	8	out	out	ADP
aji-30	105	9	in	in	ADP
aji-30	105	10	collaboration	collaboration	NOUN
aji-30	105	11	among	among	ADP
aji-30	105	12	all	all	DET
aji-30	105	13	authors	author	NOUN
aji-30	105	14	.	.	PUNCT
aji-30	106	1	author	author	NOUN
aji-30	106	2	mj	mj	PROPN
aji-30	106	3	designed	design	VERB
aji-30	106	4	the	the	DET
aji-30	106	5	study	study	NOUN
aji-30	106	6	,	,	PUNCT
aji-30	106	7	performed	perform	VERB
aji-30	106	8	the	the	DET
aji-30	106	9	statistical	statistical	ADJ
aji-30	106	10	analysis	analysis	NOUN
aji-30	106	11	,	,	PUNCT
aji-30	106	12	wrote	write	VERB
aji-30	106	13	the	the	DET
aji-30	106	14	protocol	protocol	NOUN
aji-30	106	15	and	and	CCONJ
aji-30	106	16	wrote	write	VERB
aji-30	106	17	the	the	DET
aji-30	106	18	first	first	ADJ
aji-30	106	19	draft	draft	NOUN
aji-30	106	20	of	of	ADP
aji-30	106	21	the	the	DET
aji-30	106	22	manuscript	manuscript	NOUN
aji-30	106	23	,	,	PUNCT
aji-30	106	24	managed	manage	VERB
aji-30	106	25	the	the	DET
aji-30	106	26	analyses	analysis	NOUN
aji-30	106	27	of	of	ADP
aji-30	106	28	the	the	DET
aji-30	106	29	study	study	NOUN
aji-30	106	30	and	and	CCONJ
aji-30	106	31	managed	manage	VERB
aji-30	106	32	the	the	DET
aji-30	106	33	literature	literature	NOUN
aji-30	106	34	searches	search	NOUN
aji-30	106	35	.	.	PUNCT
aji-30	107	1	author	author	PROPN
aji-30	107	2	ka	ka	PROPN
aji-30	107	3	was	be	AUX
aji-30	107	4	supervisor	supervisor	NOUN
aji-30	107	5	professor	professor	NOUN
aji-30	107	6	.	.	PUNCT
aji-30	108	1	author	author	PROPN
aji-30	108	2	hy	hy	PROPN
aji-30	108	3	was	be	AUX
aji-30	108	4	assistant	assistant	ADJ
aji-30	108	5	supervisor	supervisor	NOUN
aji-30	108	6	professor	professor	NOUN
aji-30	108	7	.	.	PUNCT
aji-30	109	1	all	all	DET
aji-30	109	2	authors	author	NOUN
aji-30	109	3	read	read	VERB
aji-30	109	4	and	and	CCONJ
aji-30	109	5	approved	approve	VERB
aji-30	109	6	the	the	DET
aji-30	109	7	final	final	ADJ
aji-30	109	8	manuscript	manuscript	NOUN
aji-30	109	9	.	.	PUNCT
aji-30	110	1	article	article	NOUN
aji-30	110	2	information	information	PROPN
aji-30	110	3	editor(s	editor(s	PROPN
aji-30	110	4	):	):	PUNCT
aji-30	110	5	(	(	PUNCT
aji-30	110	6	1	1	X
aji-30	110	7	)	)	PUNCT
aji-30	110	8	dr	dr	PROPN
aji-30	110	9	.	.	PROPN
aji-30	110	10	wagner	wagner	PROPN
aji-30	110	11	loyola	loyola	PROPN
aji-30	110	12	,	,	PUNCT
aji-30	110	13	brazilian	brazilian	ADJ
aji-30	110	14	agricultural	agricultural	ADJ
aji-30	110	15	research	research	NOUN
aji-30	110	16	corporation	corporation	NOUN
aji-30	110	17	,	,	PUNCT
aji-30	110	18	brazil	brazil	PROPN
aji-30	110	19	.	.	PUNCT
aji-30	111	1	reviewers	reviewer	NOUN
aji-30	111	2	:	:	PUNCT
aji-30	111	3	(	(	PUNCT
aji-30	111	4	1	1	X
aji-30	111	5	)	)	PUNCT
aji-30	111	6	ibrahim	ibrahim	PROPN
aji-30	111	7	mohamad	mohamad	PROPN
aji-30	111	8	saeed	saeed	PROPN
aji-30	111	9	shnawa	shnawa	PROPN
aji-30	111	10	,	,	PUNCT
aji-30	111	11	university	university	PROPN
aji-30	111	12	of	of	ADP
aji-30	111	13	qasim	qasim	PROPN
aji-30	111	14	,	,	PUNCT
aji-30	111	15	iraq	iraq	PROPN
aji-30	111	16	.	.	PUNCT
aji-30	112	1	(	(	PUNCT
aji-30	112	2	2	2	X
aji-30	112	3	)	)	PUNCT
aji-30	112	4	k.	k.	PROPN
aji-30	112	5	ramya	ramya	PROPN
aji-30	112	6	,	,	PUNCT
aji-30	112	7	tamil	tamil	PROPN
aji-30	112	8	nadu	nadu	ADJ
aji-30	112	9	veterinary	veterinary	NOUN
aji-30	112	10	and	and	CCONJ
aji-30	112	11	animal	animal	NOUN
aji-30	112	12	sciences	sciences	PROPN
aji-30	112	13	university	university	PROPN
aji-30	112	14	,	,	PUNCT
aji-30	112	15	india	india	PROPN
aji-30	112	16	.	.	PUNCT
aji-30	113	1	complete	complete	ADJ
aji-30	113	2	peer	peer	NOUN
aji-30	113	3	review	review	NOUN
aji-30	113	4	history	history	NOUN
aji-30	113	5	:	:	PUNCT
aji-30	113	6	http://www.sdiarticle4.com/review-history/61363	http://www.sdiarticle4.com/review-history/61363	VERB
aji-30	113	7	received	receive	VERB
aji-30	113	8	15	15	NUM
aji-30	113	9	july	july	PROPN
aji-30	113	10	2020	2020	NUM
aji-30	113	11	accepted	accept	VERB
aji-30	113	12	20	20	NUM
aji-30	113	13	september	september	PROPN
aji-30	113	14	2020	2020	NUM
aji-30	113	15	published	publish	VERB
aji-30	113	16	25	25	NUM
aji-30	113	17	september	september	PROPN
aji-30	113	18	2020	2020	NUM
aji-30	113	19	abstract	abstract	ADJ
aji-30	113	20	background	background	NOUN
aji-30	113	21	:	:	PUNCT
aji-30	113	22	rheumatoid	rheumatoid	VERB
aji-30	113	23	arthritis	arthritis	NOUN
aji-30	113	24	(	(	PUNCT
aji-30	113	25	ra	ra	NOUN
aji-30	113	26	)	)	PUNCT
aji-30	113	27	is	be	AUX
aji-30	113	28	a	a	DET
aji-30	113	29	chronic	chronic	ADJ
aji-30	113	30	systemic	systemic	ADJ
aji-30	113	31	disease	disease	NOUN
aji-30	113	32	,	,	PUNCT
aji-30	113	33	characterized	characterize	VERB
aji-30	113	34	by	by	ADP
aji-30	113	35	autoimmunity	autoimmunity	NOUN
aji-30	113	36	.	.	PUNCT
aji-30	114	1	one	one	NUM
aji-30	114	2	of	of	ADP
aji-30	114	3	the	the	DET
aji-30	114	4	most	most	ADV
aji-30	114	5	specific	specific	ADJ
aji-30	114	6	and	and	CCONJ
aji-30	114	7	important	important	ADJ
aji-30	114	8	diagnostic	diagnostic	ADJ
aji-30	114	9	and	and	CCONJ
aji-30	114	10	prognostic	prognostic	ADJ
aji-30	114	11	markers	marker	NOUN
aji-30	114	12	of	of	ADP
aji-30	114	13	ra	ra	PROPN
aji-30	114	14	are	be	AUX
aji-30	114	15	antibodies	antibody	NOUN
aji-30	114	16	,	,	PUNCT
aji-30	114	17	anti	anti	X
aji-30	114	18	cyclic	cyclic	ADJ
aji-30	114	19	citrullinated	citrullinate	VERB
aji-30	114	20	protein	protein	NOUN
aji-30	114	21	antibodies	antibody	NOUN
aji-30	114	22	(	(	PUNCT
aji-30	114	23	acpa	acpa	NOUN
aji-30	114	24	)	)	PUNCT
aji-30	114	25	.	.	PUNCT
aji-30	115	1	objective	objective	NOUN
aji-30	115	2	:	:	PUNCT
aji-30	115	3	the	the	DET
aji-30	115	4	purpose	purpose	NOUN
aji-30	115	5	of	of	ADP
aji-30	115	6	this	this	DET
aji-30	115	7	study	study	NOUN
aji-30	115	8	was	be	AUX
aji-30	115	9	to	to	PART
aji-30	115	10	investigate	investigate	VERB
aji-30	115	11	the	the	DET
aji-30	115	12	association	association	NOUN
aji-30	115	13	between	between	ADP
aji-30	115	14	acpa	acpa	PROPN
aji-30	115	15	(	(	PUNCT
aji-30	115	16	anti	anti	ADJ
aji-30	115	17	-	-	ADJ
aji-30	115	18	ccp	ccp	ADJ
aji-30	115	19	)	)	PUNCT
aji-30	115	20	levels	level	NOUN
aji-30	115	21	and	and	CCONJ
aji-30	115	22	radiological	radiological	ADJ
aji-30	115	23	damage	damage	NOUN
aji-30	115	24	.	.	PUNCT
aji-30	116	1	methods	method	NOUN
aji-30	116	2	:	:	PUNCT
aji-30	116	3	an	an	DET
aji-30	116	4	observational	observational	ADJ
aji-30	116	5	cross	cross	ADJ
aji-30	116	6	-	-	ADJ
aji-30	116	7	sectional	sectional	ADJ
aji-30	116	8	study	study	NOUN
aji-30	116	9	included	include	VERB
aji-30	116	10	54	54	NUM
aji-30	116	11	patients	patient	NOUN
aji-30	116	12	fulfilling	fulfil	VERB
aji-30	116	13	the	the	DET
aji-30	116	14	acr	acr	NOUN
aji-30	116	15	-	-	PUNCT
aji-30	116	16	eular	eular	ADJ
aji-30	116	17	2010	2010	NUM
aji-30	116	18	criteria	criterion	NOUN
aji-30	116	19	for	for	ADP
aji-30	116	20	ra	ra	PROPN
aji-30	116	21	,	,	PUNCT
aji-30	116	22	with	with	ADP
aji-30	116	23	minimum	minimum	ADJ
aji-30	116	24	disease	disease	NOUN
aji-30	116	25	duration	duration	NOUN
aji-30	116	26	of	of	ADP
aji-30	116	27	1	1	NUM
aji-30	116	28	year	year	NOUN
aji-30	116	29	.	.	PUNCT
aji-30	117	1	radiographs	radiograph	NOUN
aji-30	117	2	were	be	AUX
aji-30	117	3	scored	score	VERB
aji-30	117	4	using	use	VERB
aji-30	117	5	a	a	DET
aji-30	117	6	modified	modify	VERB
aji-30	117	7	sharp	sharp	ADJ
aji-30	117	8	score	score	NOUN
aji-30	117	9	(	(	PUNCT
aji-30	117	10	van	van	PROPN
aji-30	117	11	der	der	NOUN
aji-30	117	12	heijde	heijde	NOUN
aji-30	117	13	modification	modification	NOUN
aji-30	117	14	of	of	ADP
aji-30	117	15	sharp	sharp	PROPN
aji-30	117	16	's	's	PART
aji-30	117	17	score	score	NOUN
aji-30	117	18	1989	1989	NUM
aji-30	117	19	)	)	PUNCT
aji-30	117	20	.	.	PUNCT
aji-30	118	1	acpa	acpa	PROPN
aji-30	118	2	levels	level	NOUN
aji-30	118	3	were	be	AUX
aji-30	118	4	determined	determine	VERB
aji-30	118	5	using	use	VERB
aji-30	118	6	immunofluorescence	immunofluorescence	NOUN
aji-30	118	7	assay	assay	NOUN
aji-30	118	8	.	.	PUNCT
aji-30	119	1	results	result	NOUN
aji-30	119	2	:	:	PUNCT
aji-30	119	3	acpa	acpa	PROPN
aji-30	119	4	levels	level	NOUN
aji-30	119	5	were	be	AUX
aji-30	119	6	strongly	strongly	ADV
aji-30	119	7	associated	associate	VERB
aji-30	119	8	with	with	ADP
aji-30	119	9	radiographic	radiographic	ADJ
aji-30	119	10	severity	severity	NOUN
aji-30	119	11	and	and	CCONJ
aji-30	119	12	there	there	PRON
aji-30	119	13	was	be	VERB
aji-30	119	14	a	a	DET
aji-30	119	15	significant	significant	ADJ
aji-30	119	16	relationship	relationship	NOUN
aji-30	119	17	between	between	ADP
aji-30	119	18	acpa	acpa	PROPN
aji-30	119	19	levels	level	NOUN
aji-30	119	20	and	and	CCONJ
aji-30	119	21	total	total	ADJ
aji-30	119	22	sharp	sharp	ADJ
aji-30	119	23	score	score	NOUN
aji-30	119	24	(	(	PUNCT
aji-30	119	25	p=0.0001	p=0.0001	NOUN
aji-30	119	26	)	)	PUNCT
aji-30	119	27	.	.	PUNCT
aji-30	120	1	original	original	ADJ
aji-30	120	2	research	research	NOUN
aji-30	120	3	article	article	NOUN
aji-30	120	4	jnad	jnad	VERB
aji-30	120	5	et	et	PROPN
aji-30	120	6	al	al	PROPN
aji-30	120	7	.	.	PROPN
aji-30	120	8	;	;	PUNCT
aji-30	121	1	aji	aji	PROPN
aji-30	121	2	,	,	PUNCT
aji-30	121	3	3(1	3(1	NUM
aji-30	121	4	):	):	PUNCT
aji-30	121	5	305	305	NUM
aji-30	121	6	-	-	SYM
aji-30	121	7	310	310	NUM
aji-30	121	8	,	,	PUNCT
aji-30	121	9	2020	2020	NUM
aji-30	121	10	;	;	PUNCT
aji-30	121	11	article	article	NOUN
aji-30	121	12	no.aji.61363	no.aji.61363	VERB
aji-30	121	13	306	306	NUM
aji-30	121	14	conclusion	conclusion	NOUN
aji-30	121	15	:	:	PUNCT
aji-30	121	16	this	this	DET
aji-30	121	17	study	study	NOUN
aji-30	121	18	concluded	conclude	VERB
aji-30	121	19	that	that	SCONJ
aji-30	121	20	acpa	acpa	PRON
aji-30	121	21	is	be	AUX
aji-30	121	22	an	an	DET
aji-30	121	23	independent	independent	ADJ
aji-30	121	24	severity	severity	NOUN
aji-30	121	25	factor	factor	NOUN
aji-30	121	26	for	for	ADP
aji-30	121	27	ra	ra	PROPN
aji-30	121	28	,	,	PUNCT
aji-30	121	29	and	and	CCONJ
aji-30	121	30	our	our	PRON
aji-30	121	31	data	datum	NOUN
aji-30	121	32	supports	support	VERB
aji-30	121	33	the	the	DET
aji-30	121	34	association	association	NOUN
aji-30	121	35	between	between	ADP
aji-30	121	36	acpa	acpa	PRON
aji-30	121	37	and	and	CCONJ
aji-30	121	38	radiographic	radiographic	ADJ
aji-30	121	39	severity	severity	NOUN
aji-30	121	40	.	.	PUNCT
aji-30	122	1	keywords	keyword	NOUN
aji-30	122	2	:	:	PUNCT
aji-30	122	3	anti	anti	X
aji-30	122	4	cyclic	cyclic	ADJ
aji-30	122	5	citrullinated	citrullinate	VERB
aji-30	122	6	protein	protein	NOUN
aji-30	122	7	;	;	PUNCT
aji-30	122	8	type2	type2	PROPN
aji-30	122	9	(	(	PUNCT
aji-30	122	10	acpa2	acpa2	PROPN
aji-30	122	11	)	)	PUNCT
aji-30	122	12	;	;	PUNCT
aji-30	122	13	rheumatoid	rheumatoid	NOUN
aji-30	122	14	arthritis	arthritis	NOUN
aji-30	122	15	;	;	PUNCT
aji-30	122	16	chronic	chronic	ADJ
aji-30	122	17	systemic	systemic	ADJ
aji-30	122	18	disease	disease	NOUN
aji-30	122	19	.	.	PUNCT
aji-30	123	1	abbreviations	abbreviation	NOUN
aji-30	123	2	ra	ra	PROPN
aji-30	123	3	:	:	PUNCT
aji-30	123	4	rheumatoid	rheumatoid	VERB
aji-30	123	5	arthritis	arthritis	NOUN
aji-30	123	6	acpa	acpa	NOUN
aji-30	123	7	:	:	PUNCT
aji-30	123	8	anti	anti	ADJ
aji-30	123	9	citrullinated	citrullinate	VERB
aji-30	123	10	peptides	peptide	NOUN
aji-30	123	11	antibody	antibody	VERB
aji-30	123	12	anti	anti	ADJ
aji-30	123	13	-	-	ADJ
aji-30	123	14	ccp	ccp	ADJ
aji-30	123	15	:	:	PUNCT
aji-30	123	16	anti	anti	X
aji-30	123	17	cyclic	cyclic	ADJ
aji-30	123	18	citrullinated	citrullinate	VERB
aji-30	123	19	protein	protein	NOUN
aji-30	123	20	antibodies	antibodie	VERB
aji-30	123	21	acr	acr	NOUN
aji-30	123	22	:	:	PUNCT
aji-30	123	23	american	american	PROPN
aji-30	123	24	college	college	PROPN
aji-30	123	25	of	of	ADP
aji-30	123	26	rheumatology	rheumatology	PROPN
aji-30	123	27	eular	eular	ADJ
aji-30	123	28	:	:	PUNCT
aji-30	123	29	european	european	PROPN
aji-30	123	30	league	league	PROPN
aji-30	123	31	against	against	ADP
aji-30	123	32	rheumatism	rheumatism	NOUN
aji-30	123	33	rf	rf	VERB
aji-30	123	34	:	:	PUNCT
aji-30	123	35	rheumatoid	rheumatoid	VERB
aji-30	123	36	factors	factor	NOUN
aji-30	123	37	dmard	dmard	ADJ
aji-30	123	38	:	:	PUNCT
aji-30	123	39	disease	disease	NOUN
aji-30	123	40	modifying	modify	VERB
aji-30	123	41	anti	anti	ADJ
aji-30	123	42	rheumatic	rheumatic	ADJ
aji-30	123	43	drugs	drug	NOUN
aji-30	123	44	1	1	NUM
aji-30	123	45	.	.	X
aji-30	124	1	introduction	introduction	NOUN
aji-30	124	2	rheumatoid	rheumatoid	NOUN
aji-30	124	3	arthritis	arthritis	NOUN
aji-30	124	4	(	(	PUNCT
aji-30	124	5	ra	ra	NOUN
aji-30	124	6	)	)	PUNCT
aji-30	124	7	is	be	AUX
aji-30	124	8	a	a	DET
aji-30	124	9	chronic	chronic	ADJ
aji-30	124	10	systemic	systemic	ADJ
aji-30	124	11	disease	disease	NOUN
aji-30	124	12	of	of	ADP
aji-30	124	13	unknown	unknown	ADJ
aji-30	124	14	origin	origin	NOUN
aji-30	124	15	,	,	PUNCT
aji-30	124	16	characterized	characterize	VERB
aji-30	124	17	by	by	ADP
aji-30	124	18	autoimmunity	autoimmunity	NOUN
aji-30	124	19	,	,	PUNCT
aji-30	124	20	with	with	ADP
aji-30	124	21	the	the	DET
aji-30	124	22	presence	presence	NOUN
aji-30	124	23	of	of	ADP
aji-30	124	24	autoantibodies	autoantibody	NOUN
aji-30	124	25	in	in	ADP
aji-30	124	26	the	the	DET
aji-30	124	27	blood	blood	NOUN
aji-30	124	28	and	and	CCONJ
aji-30	124	29	joint	joint	ADJ
aji-30	124	30	fluid	fluid	NOUN
aji-30	124	31	.	.	PUNCT
aji-30	125	1	one	one	NUM
aji-30	125	2	of	of	ADP
aji-30	125	3	them	they	PRON
aji-30	125	4	is	be	AUX
aji-30	125	5	acpa	acpa	NOUN
aji-30	125	6	,	,	PUNCT
aji-30	125	7	which	which	DET
aji-30	125	8	state	state	VERB
aji-30	125	9	high	high	ADJ
aji-30	125	10	disease	disease	NOUN
aji-30	125	11	specificity	specificity	NOUN
aji-30	125	12	and	and	CCONJ
aji-30	125	13	may	may	AUX
aji-30	125	14	contribute	contribute	VERB
aji-30	125	15	to	to	ADP
aji-30	125	16	the	the	DET
aji-30	125	17	pathological	pathological	ADJ
aji-30	125	18	process	process	NOUN
aji-30	125	19	of	of	ADP
aji-30	125	20	the	the	DET
aji-30	125	21	disease	disease	NOUN
aji-30	125	22	such	such	ADJ
aji-30	125	23	as	as	ADP
aji-30	125	24	erosiveness	erosiveness	NOUN
aji-30	125	25	and	and	CCONJ
aji-30	125	26	synovitis	synovitis	ADJ
aji-30	125	27	[	[	X
aji-30	125	28	1	1	NUM
aji-30	125	29	]	]	PUNCT
aji-30	125	30	.	.	PUNCT
aji-30	126	1	if	if	SCONJ
aji-30	126	2	untreated	untreate	VERB
aji-30	126	3	,	,	PUNCT
aji-30	126	4	it	it	PRON
aji-30	126	5	usually	usually	ADV
aji-30	126	6	leads	lead	VERB
aji-30	126	7	to	to	ADP
aji-30	126	8	progressive	progressive	ADJ
aji-30	126	9	joint	joint	ADJ
aji-30	126	10	damage	damage	NOUN
aji-30	126	11	and	and	CCONJ
aji-30	126	12	reduction	reduction	NOUN
aji-30	126	13	of	of	ADP
aji-30	126	14	functional	functional	ADJ
aji-30	126	15	capacity	capacity	NOUN
aji-30	126	16	and	and	CCONJ
aji-30	126	17	quality	quality	NOUN
aji-30	126	18	of	of	ADP
aji-30	126	19	life	life	NOUN
aji-30	126	20	[	[	X
aji-30	126	21	2,3	2,3	NUM
aji-30	126	22	]	]	PUNCT
aji-30	126	23	.	.	PUNCT
aji-30	127	1	early	early	ADJ
aji-30	127	2	diagnosis	diagnosis	NOUN
aji-30	127	3	and	and	CCONJ
aji-30	127	4	effective	effective	ADJ
aji-30	127	5	intervention	intervention	NOUN
aji-30	127	6	may	may	AUX
aji-30	127	7	prevent	prevent	VERB
aji-30	127	8	joint	joint	ADJ
aji-30	127	9	damage	damage	NOUN
aji-30	127	10	,	,	PUNCT
aji-30	127	11	increase	increase	VERB
aji-30	127	12	the	the	DET
aji-30	127	13	possibility	possibility	NOUN
aji-30	127	14	of	of	ADP
aji-30	127	15	achieving	achieve	VERB
aji-30	127	16	remission	remission	NOUN
aji-30	127	17	and	and	CCONJ
aji-30	127	18	improve	improve	VERB
aji-30	127	19	the	the	DET
aji-30	127	20	outcome	outcome	NOUN
aji-30	127	21	[	[	X
aji-30	127	22	4	4	NUM
aji-30	127	23	]	]	PUNCT
aji-30	127	24	.	.	PUNCT
aji-30	128	1	radiography	radiography	NOUN
aji-30	128	2	is	be	AUX
aji-30	128	3	the	the	DET
aji-30	128	4	most	most	ADV
aji-30	128	5	common	common	ADJ
aji-30	128	6	method	method	NOUN
aji-30	128	7	for	for	ADP
aji-30	128	8	evaluating	evaluate	VERB
aji-30	128	9	the	the	DET
aji-30	128	10	existence	existence	NOUN
aji-30	128	11	of	of	ADP
aji-30	128	12	structural	structural	ADJ
aji-30	128	13	damage	damage	NOUN
aji-30	128	14	,	,	PUNCT
aji-30	128	15	which	which	PRON
aji-30	128	16	results	result	VERB
aji-30	128	17	from	from	ADP
aji-30	128	18	cumulative	cumulative	ADJ
aji-30	128	19	disease	disease	NOUN
aji-30	128	20	activity	activity	NOUN
aji-30	128	21	,	,	PUNCT
aji-30	128	22	and	and	CCONJ
aji-30	128	23	determining	determine	VERB
aji-30	128	24	the	the	DET
aji-30	128	25	effectiveness	effectiveness	NOUN
aji-30	128	26	of	of	ADP
aji-30	128	27	treatment	treatment	NOUN
aji-30	128	28	by	by	ADP
aji-30	128	29	estimating	estimate	VERB
aji-30	128	30	bone	bone	NOUN
aji-30	128	31	erosions	erosion	NOUN
aji-30	128	32	and	and	CCONJ
aji-30	128	33	joint	joint	ADJ
aji-30	128	34	space	space	NOUN
aji-30	128	35	narrowing	narrow	VERB
aji-30	128	36	on	on	ADP
aji-30	128	37	conventional	conventional	ADJ
aji-30	128	38	radiography	radiography	NOUN
aji-30	128	39	[	[	X
aji-30	128	40	5	5	NUM
aji-30	128	41	]	]	PUNCT
aji-30	128	42	.	.	PUNCT
aji-30	129	1	acpa	acpa	VERB
aji-30	129	2	positive	positive	ADJ
aji-30	129	3	patients	patient	NOUN
aji-30	129	4	are	be	AUX
aji-30	129	5	at	at	ADP
aji-30	129	6	particularly	particularly	ADV
aji-30	129	7	high	high	ADJ
aji-30	129	8	risk	risk	NOUN
aji-30	129	9	for	for	ADP
aji-30	129	10	developing	develop	VERB
aji-30	129	11	severe	severe	ADJ
aji-30	129	12	forms	form	NOUN
aji-30	129	13	of	of	ADP
aji-30	129	14	ra	ra	PROPN
aji-30	129	15	and	and	CCONJ
aji-30	129	16	severe	severe	ADJ
aji-30	129	17	radiographic	radiographic	ADJ
aji-30	129	18	damage	damage	NOUN
aji-30	129	19	,	,	PUNCT
aji-30	129	20	as	as	SCONJ
aji-30	129	21	they	they	PRON
aji-30	129	22	are	be	AUX
aji-30	129	23	independent	independent	ADJ
aji-30	129	24	severity	severity	NOUN
aji-30	129	25	factor	factor	NOUN
aji-30	129	26	for	for	ADP
aji-30	129	27	rheumatoid	rheumatoid	NOUN
aji-30	129	28	arthritis	arthritis	NOUN
aji-30	129	29	(	(	PUNCT
aji-30	129	30	ra	ra	NOUN
aji-30	129	31	)	)	PUNCT
aji-30	129	32	,	,	PUNCT
aji-30	129	33	and	and	CCONJ
aji-30	129	34	may	may	AUX
aji-30	129	35	be	be	AUX
aji-30	129	36	very	very	ADV
aji-30	129	37	useful	useful	ADJ
aji-30	129	38	biomarkers	biomarker	NOUN
aji-30	129	39	to	to	PART
aji-30	129	40	predict	predict	VERB
aji-30	129	41	disease	disease	NOUN
aji-30	129	42	damage	damage	NOUN
aji-30	130	1	[	[	X
aji-30	130	2	6,7	6,7	NUM
aji-30	130	3	]	]	PUNCT
aji-30	130	4	.	.	PUNCT
aji-30	131	1	there	there	PRON
aji-30	131	2	is	be	VERB
aji-30	131	3	no	no	DET
aji-30	131	4	research	research	NOUN
aji-30	131	5	on	on	ADP
aji-30	131	6	association	association	NOUN
aji-30	131	7	between	between	ADP
aji-30	131	8	acpa	acpa	PRON
aji-30	131	9	and	and	CCONJ
aji-30	131	10	structural	structural	ADJ
aji-30	131	11	damage	damage	NOUN
aji-30	131	12	in	in	ADP
aji-30	131	13	ra	ra	PROPN
aji-30	131	14	patients	patient	NOUN
aji-30	131	15	in	in	ADP
aji-30	131	16	syria	syria	PROPN
aji-30	131	17	.	.	PUNCT
aji-30	132	1	the	the	DET
aji-30	132	2	objective	objective	NOUN
aji-30	132	3	of	of	ADP
aji-30	132	4	the	the	DET
aji-30	132	5	present	present	ADJ
aji-30	132	6	work	work	NOUN
aji-30	132	7	was	be	AUX
aji-30	132	8	to	to	PART
aji-30	132	9	map	map	VERB
aji-30	132	10	the	the	DET
aji-30	132	11	possible	possible	ADJ
aji-30	132	12	association	association	NOUN
aji-30	132	13	betweenacpa2	betweenacpa2	NOUN
aji-30	132	14	and	and	CCONJ
aji-30	132	15	the	the	DET
aji-30	132	16	radiographic	radiographic	ADJ
aji-30	132	17	severity	severity	NOUN
aji-30	132	18	of	of	ADP
aji-30	132	19	the	the	DET
aji-30	132	20	ra	ra	PROPN
aji-30	132	21	patient	patient	ADJ
aji-30	132	22	joints	joint	NOUN
aji-30	132	23	.	.	PUNCT
aji-30	133	1	2	2	X
aji-30	133	2	.	.	X
aji-30	133	3	methods	method	NOUN
aji-30	133	4	and	and	CCONJ
aji-30	133	5	patients	patient	NOUN
aji-30	133	6	an	an	DET
aji-30	133	7	observational	observational	ADJ
aji-30	133	8	cross	cross	ADJ
aji-30	133	9	-	-	ADJ
aji-30	133	10	sectional	sectional	ADJ
aji-30	133	11	study	study	NOUN
aji-30	133	12	included	include	VERB
aji-30	133	13	patients	patient	NOUN
aji-30	133	14	(	(	PUNCT
aji-30	133	15	n=54	n=54	PROPN
aji-30	133	16	;	;	PUNCT
aji-30	133	17	45	45	NUM
aji-30	133	18	female	female	NOUN
aji-30	133	19	,	,	PUNCT
aji-30	133	20	9	9	NUM
aji-30	133	21	male	male	NOUN
aji-30	133	22	)	)	PUNCT
aji-30	133	23	with	with	ADP
aji-30	133	24	ra	ra	PROPN
aji-30	133	25	(	(	PUNCT
aji-30	133	26	duration	duration	NOUN
aji-30	133	27	more	more	ADJ
aji-30	133	28	than	than	ADP
aji-30	133	29	1	1	NUM
aji-30	133	30	year	year	NOUN
aji-30	133	31	)	)	PUNCT
aji-30	133	32	fulfilling	fulfil	VERB
aji-30	133	33	the	the	DET
aji-30	133	34	acreular	acreular	ADJ
aji-30	133	35	2010	2010	NUM
aji-30	133	36	criteria	criterion	NOUN
aji-30	133	37	for	for	ADP
aji-30	133	38	ra	ra	PROPN
aji-30	133	39	,	,	PUNCT
aji-30	133	40	at	at	ADP
aji-30	133	41	the	the	DET
aji-30	133	42	department	department	NOUN
aji-30	133	43	of	of	ADP
aji-30	133	44	rheumatology	rheumatology	NOUN
aji-30	133	45	,	,	PUNCT
aji-30	133	46	tishreen	tishreen	NUM
aji-30	133	47	university	university	NOUN
aji-30	133	48	hospital	hospital	NOUN
aji-30	133	49	,	,	PUNCT
aji-30	133	50	lattakia	lattakia	PROPN
aji-30	133	51	,	,	PUNCT
aji-30	133	52	syria	syria	PROPN
aji-30	133	53	.	.	PUNCT
aji-30	134	1	over	over	ADP
aji-30	134	2	1year	1year	NUM
aji-30	134	3	period	period	NOUN
aji-30	134	4	from	from	ADP
aji-30	134	5	april	april	PROPN
aji-30	134	6	2019	2019	NUM
aji-30	134	7	to	to	ADP
aji-30	134	8	march	march	PROPN
aji-30	134	9	2020	2020	NUM
aji-30	134	10	,	,	PUNCT
aji-30	134	11	patients	patient	NOUN
aji-30	134	12	having	have	VERB
aji-30	134	13	an	an	DET
aji-30	134	14	overlap	overlap	NOUN
aji-30	134	15	of	of	ADP
aji-30	134	16	ra	ra	PROPN
aji-30	134	17	with	with	ADP
aji-30	134	18	other	other	ADJ
aji-30	134	19	rheumatic	rheumatic	ADJ
aji-30	134	20	disease	disease	NOUN
aji-30	134	21	like	like	ADP
aji-30	134	22	gout	gout	NOUN
aji-30	134	23	were	be	AUX
aji-30	134	24	excluded	exclude	VERB
aji-30	134	25	from	from	ADP
aji-30	134	26	the	the	DET
aji-30	134	27	study	study	NOUN
aji-30	134	28	.	.	PUNCT
aji-30	135	1	radiographs	radiograph	NOUN
aji-30	135	2	of	of	ADP
aji-30	135	3	hand	hand	NOUN
aji-30	135	4	and	and	CCONJ
aji-30	135	5	feet	foot	NOUN
aji-30	135	6	were	be	AUX
aji-30	135	7	scored	score	VERB
aji-30	135	8	using	use	VERB
aji-30	135	9	a	a	DET
aji-30	135	10	modified	modify	VERB
aji-30	135	11	sharp	sharp	ADJ
aji-30	135	12	score	score	NOUN
aji-30	135	13	(	(	PUNCT
aji-30	135	14	van	van	PROPN
aji-30	135	15	der	der	NOUN
aji-30	135	16	heijde	heijde	NOUN
aji-30	135	17	modification	modification	NOUN
aji-30	135	18	of	of	ADP
aji-30	135	19	sharp	sharp	PROPN
aji-30	135	20	's	's	PART
aji-30	135	21	score	score	NOUN
aji-30	135	22	)	)	PUNCT
aji-30	135	23	.	.	PUNCT
aji-30	136	1	2.1	2.1	NUM
aji-30	136	2	antibody	antibody	NOUN
aji-30	136	3	measurement	measurement	NOUN
aji-30	136	4	(	(	PUNCT
aji-30	136	5	acpa	acpa	NOUN
aji-30	136	6	/	/	SYM
aji-30	136	7	anti	anti	X
aji-30	136	8	ccp	ccp	PROPN
aji-30	136	9	)	)	PUNCT
aji-30	136	10	anti	anti	PROPN
aji-30	136	11	ccp	ccp	PROPN
aji-30	136	12	were	be	AUX
aji-30	136	13	measured	measure	VERB
aji-30	136	14	,	,	PUNCT
aji-30	136	15	in	in	ADP
aji-30	136	16	a	a	DET
aji-30	136	17	blind	blind	ADJ
aji-30	136	18	fashion	fashion	NOUN
aji-30	136	19	,	,	PUNCT
aji-30	136	20	at	at	ADP
aji-30	136	21	the	the	DET
aji-30	136	22	immunological	immunological	ADJ
aji-30	136	23	laboratory	laboratory	NOUN
aji-30	136	24	in	in	ADP
aji-30	136	25	tishreen	tishreen	ADJ
aji-30	136	26	hospital	hospital	NOUN
aji-30	136	27	using	use	VERB
aji-30	136	28	an	an	DET
aji-30	136	29	(	(	PUNCT
aji-30	136	30	i	i	PROPN
aji-30	136	31	-	-	PUNCT
aji-30	136	32	chromα	chromα	NOUN
aji-30	136	33	anti	anti	PROPN
aji-30	136	34	-	-	ADJ
aji-30	136	35	ccp	ccp	ADJ
aji-30	136	36	plus	plus	CCONJ
aji-30	136	37	)	)	PUNCT
aji-30	136	38	kit	kit	NOUN
aji-30	136	39	based	base	VERB
aji-30	136	40	on	on	ADP
aji-30	136	41	the	the	DET
aji-30	136	42	immunofluorescence	immunofluorescence	NOUN
aji-30	136	43	assay	assay	NOUN
aji-30	136	44	method	method	NOUN
aji-30	136	45	.	.	PUNCT
aji-30	137	1	a	a	DET
aji-30	137	2	value	value	NOUN
aji-30	137	3	of	of	ADP
aji-30	137	4	>	>	X
aji-30	137	5	5.0	5.0	NUM
aji-30	137	6	u	u	NOUN
aji-30	137	7	/	/	SYM
aji-30	137	8	ml	ml	PROPN
aji-30	137	9	was	be	AUX
aji-30	137	10	considered	consider	VERB
aji-30	137	11	positive	positive	ADJ
aji-30	137	12	as	as	ADP
aji-30	137	13	per	per	ADP
aji-30	137	14	the	the	DET
aji-30	137	15	manufacturers	manufacturer	NOUN
aji-30	137	16	'	'	PART
aji-30	137	17	recommendations	recommendation	NOUN
aji-30	137	18	.	.	PUNCT
aji-30	138	1	rf	rf	PRON
aji-30	138	2	was	be	AUX
aji-30	138	3	measured	measure	VERB
aji-30	138	4	using	use	VERB
aji-30	138	5	the	the	DET
aji-30	138	6	standard	standard	ADJ
aji-30	138	7	latex	latex	NOUN
aji-30	138	8	agglutination	agglutination	NOUN
aji-30	138	9	technique	technique	NOUN
aji-30	138	10	.	.	PUNCT
aji-30	139	1	2.2	2.2	NUM
aji-30	139	2	measure	measure	NOUN
aji-30	139	3	of	of	ADP
aji-30	139	4	disease	disease	NOUN
aji-30	139	5	outcome	outcome	NOUN
aji-30	139	6	(	(	PUNCT
aji-30	139	7	structural	structural	ADJ
aji-30	139	8	damage	damage	NOUN
aji-30	139	9	)	)	PUNCT
aji-30	139	10	the	the	DET
aji-30	139	11	radiographs	radiograph	NOUN
aji-30	139	12	were	be	AUX
aji-30	139	13	evaluated	evaluate	VERB
aji-30	139	14	by	by	ADP
aji-30	139	15	two	two	NUM
aji-30	139	16	senior	senior	ADJ
aji-30	139	17	rheumatologists	rheumatologist	NOUN
aji-30	139	18	in	in	ADP
aji-30	139	19	a	a	DET
aji-30	139	20	blind	blind	ADJ
aji-30	139	21	fashion	fashion	NOUN
aji-30	139	22	regarding	regard	VERB
aji-30	139	23	serology	serology	NOUN
aji-30	139	24	and	and	CCONJ
aji-30	139	25	clinical	clinical	ADJ
aji-30	139	26	status	status	NOUN
aji-30	139	27	,	,	PUNCT
aji-30	139	28	with	with	ADP
aji-30	139	29	high	high	ADJ
aji-30	139	30	concordance	concordance	NOUN
aji-30	139	31	between	between	ADP
aji-30	139	32	them	they	PRON
aji-30	139	33	.	.	PUNCT
aji-30	140	1	posterior	posterior	ADJ
aji-30	140	2	anterior	anterior	ADJ
aji-30	140	3	radiographs	radiograph	NOUN
aji-30	140	4	of	of	ADP
aji-30	140	5	the	the	DET
aji-30	140	6	hands	hand	NOUN
aji-30	140	7	,	,	PUNCT
aji-30	140	8	wrists	wrist	NOUN
aji-30	140	9	,	,	PUNCT
aji-30	140	10	and	and	CCONJ
aji-30	140	11	feet	foot	NOUN
aji-30	140	12	were	be	AUX
aji-30	140	13	obtained	obtain	VERB
aji-30	140	14	and	and	CCONJ
aji-30	140	15	were	be	AUX
aji-30	140	16	examined	examine	VERB
aji-30	140	17	blind	blind	ADJ
aji-30	140	18	by	by	ADP
aji-30	140	19	a	a	DET
aji-30	140	20	two	two	NUM
aji-30	140	21	rheumatologists	rheumatologist	NOUN
aji-30	140	22	,	,	PUNCT
aji-30	140	23	and	and	CCONJ
aji-30	140	24	graded	grade	VERB
aji-30	140	25	according	accord	VERB
aji-30	140	26	to	to	ADP
aji-30	140	27	modified	modify	VERB
aji-30	140	28	sharp	sharp	ADJ
aji-30	140	29	score	score	NOUN
aji-30	140	30	(	(	PUNCT
aji-30	140	31	van	van	PROPN
aji-30	140	32	der	der	NOUN
aji-30	140	33	heijde	heijde	NOUN
aji-30	140	34	modification	modification	NOUN
aji-30	140	35	of	of	ADP
aji-30	140	36	sharp	sharp	PROPN
aji-30	140	37	's	's	PART
aji-30	140	38	score	score	NOUN
aji-30	140	39	)	)	PUNCT
aji-30	140	40	in	in	ADP
aji-30	140	41	comparison	comparison	NOUN
aji-30	140	42	with	with	ADP
aji-30	140	43	standard	standard	ADJ
aji-30	140	44	reference	reference	NOUN
aji-30	140	45	films	film	NOUN
aji-30	140	46	.	.	PUNCT
aji-30	141	1	jnad	jnad	PROPN
aji-30	141	2	et	et	PROPN
aji-30	141	3	al	al	PROPN
aji-30	141	4	.	.	PROPN
aji-30	141	5	;	;	PUNCT
aji-30	141	6	aji	aji	PROPN
aji-30	141	7	,	,	PUNCT
aji-30	141	8	3(1	3(1	NUM
aji-30	141	9	):	):	PUNCT
aji-30	141	10	305	305	NUM
aji-30	141	11	-	-	SYM
aji-30	141	12	310	310	NUM
aji-30	141	13	,	,	PUNCT
aji-30	141	14	2020	2020	NUM
aji-30	141	15	;	;	PUNCT
aji-30	141	16	article	article	NOUN
aji-30	141	17	no.aji.61363	no.aji.61363	VERB
aji-30	141	18	307	307	NUM
aji-30	141	19	the	the	DET
aji-30	141	20	scoring	scoring	NOUN
aji-30	141	21	system	system	NOUN
aji-30	141	22	included	include	VERB
aji-30	141	23	erosion	erosion	NOUN
aji-30	141	24	score	score	NOUN
aji-30	141	25	:	:	PUNCT
aji-30	141	26	16	16	NUM
aji-30	141	27	locations	location	NOUN
aji-30	141	28	in	in	ADP
aji-30	141	29	each	each	DET
aji-30	141	30	hand	hand	NOUN
aji-30	141	31	and	and	CCONJ
aji-30	141	32	wrist	wrist	NOUN
aji-30	141	33	,	,	PUNCT
aji-30	141	34	and	and	CCONJ
aji-30	141	35	12	12	NUM
aji-30	141	36	location	location	NOUN
aji-30	141	37	in	in	ADP
aji-30	141	38	each	each	DET
aji-30	141	39	foot	foot	NOUN
aji-30	141	40	were	be	AUX
aji-30	141	41	scored	score	VERB
aji-30	141	42	.	.	PUNCT
aji-30	142	1	each	each	DET
aji-30	142	2	location	location	NOUN
aji-30	142	3	in	in	ADP
aji-30	142	4	the	the	DET
aji-30	142	5	hand	hand	NOUN
aji-30	142	6	/	/	SYM
aji-30	142	7	wrist	wrist	NOUN
aji-30	142	8	and	and	CCONJ
aji-30	142	9	foot	foot	NOUN
aji-30	142	10	was	be	AUX
aji-30	142	11	scored	score	VERB
aji-30	142	12	individually	individually	ADV
aji-30	142	13	using	use	VERB
aji-30	142	14	a	a	DET
aji-30	142	15	6	6	NUM
aji-30	142	16	-	-	PUNCT
aji-30	142	17	point	point	NOUN
aji-30	142	18	scale	scale	NOUN
aji-30	142	19	from	from	ADP
aji-30	142	20	0	0	NUM
aji-30	142	21	to	to	ADP
aji-30	142	22	5	5	NUM
aji-30	142	23	based	base	VERB
aji-30	142	24	on	on	ADP
aji-30	142	25	the	the	DET
aji-30	142	26	number	number	NOUN
aji-30	142	27	and	and	CCONJ
aji-30	142	28	size	size	NOUN
aji-30	142	29	of	of	ADP
aji-30	142	30	discrete	discrete	ADJ
aji-30	142	31	erosions	erosion	NOUN
aji-30	142	32	in	in	ADP
aji-30	142	33	each	each	DET
aji-30	142	34	location	location	NOUN
aji-30	142	35	.	.	PUNCT
aji-30	143	1	joint	joint	ADJ
aji-30	143	2	space	space	NOUN
aji-30	143	3	narrowing	narrowing	NOUN
aji-30	143	4	(	(	PUNCT
aji-30	143	5	jsn	jsn	NOUN
aji-30	143	6	)	)	PUNCT
aji-30	143	7	score	score	NOUN
aji-30	143	8	:	:	PUNCT
aji-30	143	9	15	15	NUM
aji-30	143	10	locations	location	NOUN
aji-30	143	11	in	in	ADP
aji-30	143	12	each	each	DET
aji-30	143	13	hand	hand	NOUN
aji-30	143	14	and	and	CCONJ
aji-30	143	15	wrist	wrist	NOUN
aji-30	143	16	,	,	PUNCT
aji-30	143	17	and	and	CCONJ
aji-30	143	18	6	6	NUM
aji-30	143	19	locations	location	NOUN
aji-30	143	20	in	in	ADP
aji-30	143	21	each	each	DET
aji-30	143	22	foot	foot	NOUN
aji-30	143	23	were	be	AUX
aji-30	143	24	scored	score	VERB
aji-30	143	25	using	use	VERB
aji-30	143	26	a	a	DET
aji-30	143	27	5	5	NUM
aji-30	143	28	-	-	PUNCT
aji-30	143	29	point	point	NOUN
aji-30	143	30	scale	scale	NOUN
aji-30	143	31	(	(	PUNCT
aji-30	143	32	from	from	ADP
aji-30	143	33	0	0	NUM
aji-30	143	34	to	to	ADP
aji-30	143	35	4	4	NUM
aji-30	143	36	)	)	PUNCT
aji-30	143	37	.	.	PUNCT
aji-30	144	1	the	the	DET
aji-30	144	2	maximum	maximum	ADJ
aji-30	144	3	erosion	erosion	NOUN
aji-30	144	4	score	score	NOUN
aji-30	144	5	is	be	AUX
aji-30	144	6	160	160	NUM
aji-30	144	7	for	for	ADP
aji-30	144	8	hands	hand	NOUN
aji-30	144	9	and	and	CCONJ
aji-30	144	10	wrists	wrist	NOUN
aji-30	144	11	,	,	PUNCT
aji-30	144	12	and	and	CCONJ
aji-30	144	13	120	120	NUM
aji-30	144	14	for	for	ADP
aji-30	144	15	feet	foot	NOUN
aji-30	144	16	.	.	PUNCT
aji-30	145	1	the	the	DET
aji-30	145	2	maximum	maximum	PROPN
aji-30	145	3	jns	jns	PROPN
aji-30	145	4	score	score	NOUN
aji-30	145	5	is	be	AUX
aji-30	145	6	120	120	NUM
aji-30	145	7	for	for	ADP
aji-30	145	8	hands	hand	NOUN
aji-30	145	9	and	and	CCONJ
aji-30	145	10	wrists	wrist	NOUN
aji-30	145	11	,	,	PUNCT
aji-30	145	12	and	and	CCONJ
aji-30	145	13	48	48	NUM
aji-30	145	14	for	for	ADP
aji-30	145	15	feet	foot	NOUN
aji-30	145	16	.	.	PUNCT
aji-30	146	1	the	the	DET
aji-30	146	2	total	total	ADJ
aji-30	146	3	score	score	NOUN
aji-30	146	4	ranges	range	VERB
aji-30	146	5	from	from	ADP
aji-30	146	6	0	0	NUM
aji-30	146	7	to	to	ADP
aji-30	146	8	448	448	NUM
aji-30	147	1	[	[	X
aji-30	147	2	8	8	NUM
aji-30	147	3	]	]	PUNCT
aji-30	147	4	.	.	PUNCT
aji-30	148	1	2.3	2.3	NUM
aji-30	148	2	statistics	statistic	NOUN
aji-30	148	3	all	all	DET
aji-30	148	4	data	datum	NOUN
aji-30	148	5	were	be	AUX
aji-30	148	6	analyzed	analyze	VERB
aji-30	148	7	using	use	VERB
aji-30	148	8	the	the	DET
aji-30	148	9	statistical	statistical	ADJ
aji-30	148	10	package	package	NOUN
aji-30	148	11	for	for	ADP
aji-30	148	12	social	social	ADJ
aji-30	148	13	sciences	science	NOUN
aji-30	148	14	(	(	PUNCT
aji-30	148	15	spss	spss	PROPN
aji-30	148	16	,	,	PUNCT
aji-30	148	17	version	version	NOUN
aji-30	148	18	20	20	NUM
aji-30	148	19	)	)	PUNCT
aji-30	148	20	.	.	PUNCT
aji-30	149	1	data	datum	NOUN
aji-30	149	2	were	be	AUX
aji-30	149	3	presented	present	VERB
aji-30	149	4	in	in	ADP
aji-30	149	5	simple	simple	ADJ
aji-30	149	6	measures	measure	NOUN
aji-30	149	7	of	of	ADP
aji-30	149	8	frequency	frequency	NOUN
aji-30	149	9	,	,	PUNCT
aji-30	149	10	percentage	percentage	NOUN
aji-30	149	11	,	,	PUNCT
aji-30	149	12	mean	mean	VERB
aji-30	149	13	,	,	PUNCT
aji-30	149	14	and	and	CCONJ
aji-30	149	15	standard	standard	ADJ
aji-30	149	16	deviation	deviation	NOUN
aji-30	149	17	.	.	PUNCT
aji-30	150	1	non	non	ADJ
aji-30	150	2	-	-	ADJ
aji-30	150	3	parametric	parametric	ADJ
aji-30	150	4	test	test	NOUN
aji-30	150	5	mann	mann	PROPN
aji-30	150	6	whitney	whitney	PROPN
aji-30	150	7	used	use	VERB
aji-30	150	8	for	for	ADP
aji-30	150	9	nonnormally	nonnormally	ADV
aji-30	150	10	distributed	distribute	VERB
aji-30	150	11	data	datum	NOUN
aji-30	150	12	,	,	PUNCT
aji-30	150	13	while	while	SCONJ
aji-30	150	14	correlation	correlation	NOUN
aji-30	150	15	between	between	ADP
aji-30	150	16	quantitative	quantitative	ADJ
aji-30	150	17	data	datum	NOUN
aji-30	150	18	were	be	AUX
aji-30	150	19	tested	test	VERB
aji-30	150	20	using	use	VERB
aji-30	150	21	person	person	NOUN
aji-30	150	22	correlation	correlation	NOUN
aji-30	150	23	.	.	PUNCT
aji-30	151	1	results	result	NOUN
aji-30	151	2	were	be	AUX
aji-30	151	3	considered	consider	VERB
aji-30	151	4	statistically	statistically	ADV
aji-30	151	5	significant	significant	ADJ
aji-30	151	6	with	with	ADP
aji-30	151	7	a	a	DET
aji-30	151	8	p	p	NOUN
aji-30	151	9	-	-	PUNCT
aji-30	151	10	value<5	value<5	NOUN
aji-30	151	11	%	%	NOUN
aji-30	151	12	.	.	PUNCT
aji-30	152	1	fig	fig	NOUN
aji-30	152	2	.	.	PUNCT
aji-30	153	1	1	1	X
aji-30	153	2	.	.	X
aji-30	153	3	distribution	distribution	NOUN
aji-30	153	4	of	of	ADP
aji-30	153	5	patients	patient	NOUN
aji-30	153	6	according	accord	VERB
aji-30	153	7	to	to	ADP
aji-30	153	8	sex	sex	NOUN
aji-30	153	9	3	3	NUM
aji-30	153	10	.	.	PUNCT
aji-30	153	11	results	result	VERB
aji-30	153	12	the	the	DET
aji-30	153	13	cross	cross	ADJ
aji-30	153	14	-	-	ADJ
aji-30	153	15	sectional	sectional	ADJ
aji-30	153	16	study	study	NOUN
aji-30	153	17	includes	include	VERB
aji-30	153	18	54	54	NUM
aji-30	153	19	patients	patient	NOUN
aji-30	153	20	(	(	PUNCT
aji-30	153	21	45	45	NUM
aji-30	153	22	female	female	NOUN
aji-30	153	23	,	,	PUNCT
aji-30	153	24	9	9	NUM
aji-30	153	25	male	male	NOUN
aji-30	153	26	)	)	PUNCT
aji-30	153	27	with	with	ADP
aji-30	153	28	ra	ra	PROPN
aji-30	153	29	,	,	PUNCT
aji-30	153	30	the	the	DET
aji-30	153	31	median	median	PROPN
aji-30	153	32	(	(	PUNCT
aji-30	153	33	iqr	iqr	PROPN
aji-30	153	34	,	,	PUNCT
aji-30	153	35	interquartile	interquartile	ADJ
aji-30	153	36	range	range	NOUN
aji-30	153	37	)	)	PUNCT
aji-30	153	38	age	age	NOUN
aji-30	153	39	was	be	AUX
aji-30	153	40	50.5	50.5	NUM
aji-30	153	41	(	(	PUNCT
aji-30	153	42	27	27	NUM
aji-30	153	43	-	-	SYM
aji-30	153	44	80	80	NUM
aji-30	153	45	)	)	PUNCT
aji-30	154	1	yr	yr	NOUN
aji-30	154	2	.	.	PUNCT
aji-30	155	1	the	the	DET
aji-30	155	2	median	median	PROPN
aji-30	155	3	(	(	PUNCT
aji-30	155	4	iqr	iqr	PROPN
aji-30	155	5	,	,	PUNCT
aji-30	155	6	interquartile	interquartile	ADJ
aji-30	155	7	range	range	NOUN
aji-30	155	8	)	)	PUNCT
aji-30	155	9	disease	disease	NOUN
aji-30	155	10	duration	duration	NOUN
aji-30	155	11	was	be	AUX
aji-30	155	12	2.7	2.7	NUM
aji-30	155	13	year	year	NOUN
aji-30	155	14	(	(	PUNCT
aji-30	155	15	1	1	NUM
aji-30	155	16	-	-	SYM
aji-30	155	17	20	20	NUM
aji-30	155	18	)	)	PUNCT
aji-30	155	19	yr	yr	NOUN
aji-30	155	20	,	,	PUNCT
aji-30	155	21	the	the	DET
aji-30	155	22	proportion	proportion	NOUN
aji-30	155	23	of	of	ADP
aji-30	155	24	females	female	NOUN
aji-30	155	25	in	in	ADP
aji-30	155	26	the	the	DET
aji-30	155	27	study	study	NOUN
aji-30	155	28	was	be	AUX
aji-30	155	29	83.3	83.3	NUM
aji-30	155	30	%	%	NOUN
aji-30	155	31	.	.	PUNCT
aji-30	156	1	94.4	94.4	NUM
aji-30	156	2	%	%	NOUN
aji-30	156	3	of	of	ADP
aji-30	156	4	the	the	DET
aji-30	156	5	patients	patient	NOUN
aji-30	156	6	were	be	AUX
aji-30	156	7	treated	treat	VERB
aji-30	156	8	with	with	ADP
aji-30	156	9	dmards	dmard	NOUN
aji-30	156	10	.	.	PUNCT
aji-30	157	1	about	about	ADV
aji-30	157	2	68.5	68.5	NUM
aji-30	157	3	per	per	ADP
aji-30	157	4	cent	cent	NOUN
aji-30	157	5	(	(	PUNCT
aji-30	157	6	n=38	n=38	ADJ
aji-30	157	7	)	)	PUNCT
aji-30	157	8	patients	patient	NOUN
aji-30	157	9	were	be	AUX
aji-30	157	10	seropositive	seropositive	ADJ
aji-30	157	11	(	(	PUNCT
aji-30	157	12	positive	positive	ADJ
aji-30	157	13	for	for	ADP
aji-30	157	14	rf	rf	NOUN
aji-30	157	15	)	)	PUNCT
aji-30	157	16	,	,	PUNCT
aji-30	157	17	and	and	CCONJ
aji-30	157	18	81.5	81.5	NUM
aji-30	157	19	per	per	ADP
aji-30	157	20	cent	cent	NOUN
aji-30	157	21	(	(	PUNCT
aji-30	157	22	n=44	n=44	NOUN
aji-30	157	23	)	)	PUNCT
aji-30	157	24	patients	patient	NOUN
aji-30	157	25	had	have	VERB
aji-30	157	26	erosive	erosive	ADJ
aji-30	157	27	disease	disease	NOUN
aji-30	157	28	.	.	PUNCT
aji-30	158	1	on	on	ADP
aji-30	158	2	bivariate	bivariate	ADJ
aji-30	158	3	analysis	analysis	NOUN
aji-30	158	4	,	,	PUNCT
aji-30	158	5	patients	patient	NOUN
aji-30	158	6	with	with	ADP
aji-30	158	7	erosive	erosive	ADJ
aji-30	158	8	disease	disease	NOUN
aji-30	158	9	had	have	VERB
aji-30	158	10	a	a	DET
aji-30	158	11	significantly	significantly	ADV
aji-30	158	12	higher	high	ADJ
aji-30	158	13	disease	disease	NOUN
aji-30	158	14	duration	duration	NOUN
aji-30	158	15	,	,	PUNCT
aji-30	158	16	dmard	dmard	ADJ
aji-30	158	17	naïve	naïve	ADJ
aji-30	158	18	period	period	NOUN
aji-30	158	19	,	,	PUNCT
aji-30	158	20	rf	rf	NOUN
aji-30	158	21	positivity	positivity	NOUN
aji-30	158	22	and	and	CCONJ
aji-30	158	23	acpa	acpa	VERB
aji-30	158	24	titers	titer	NOUN
aji-30	158	25	than	than	ADP
aji-30	158	26	patients	patient	NOUN
aji-30	158	27	with	with	ADP
aji-30	158	28	non	non	ADJ
aji-30	158	29	-	-	ADJ
aji-30	158	30	erosive	erosive	ADJ
aji-30	158	31	disease	disease	NOUN
aji-30	158	32	(	(	PUNCT
aji-30	158	33	table	table	NOUN
aji-30	158	34	1	1	NUM
aji-30	158	35	)	)	PUNCT
aji-30	158	36	.	.	PUNCT
aji-30	159	1	3.1	3.1	NUM
aji-30	159	2	association	association	NOUN
aji-30	159	3	among	among	ADP
aji-30	159	4	radiographic	radiographic	ADJ
aji-30	159	5	outcome	outcome	NOUN
aji-30	159	6	and	and	CCONJ
aji-30	159	7	anti	anti	ADJ
aji-30	159	8	-	-	ADJ
aji-30	159	9	ccp2	ccp2	ADJ
aji-30	159	10	(	(	PUNCT
aji-30	159	11	acpa	acpa	NOUN
aji-30	159	12	)	)	PUNCT
aji-30	159	13	status	status	NOUN
aji-30	159	14	in	in	ADP
aji-30	159	15	our	our	PRON
aji-30	159	16	study	study	NOUN
aji-30	159	17	acpa	acpa	NOUN
aji-30	159	18	titers	titer	NOUN
aji-30	159	19	were	be	AUX
aji-30	159	20	strongly	strongly	ADV
aji-30	159	21	associated	associate	VERB
aji-30	159	22	with	with	ADP
aji-30	159	23	radiographic	radiographic	ADJ
aji-30	159	24	severity	severity	NOUN
aji-30	159	25	as	as	SCONJ
aji-30	159	26	measured	measure	VERB
aji-30	159	27	using	use	VERB
aji-30	159	28	sharp	sharp	ADJ
aji-30	159	29	van	van	PROPN
aji-30	159	30	der	der	ADJ
aji-30	159	31	heijde	heijde	NOUN
aji-30	159	32	score	score	NOUN
aji-30	159	33	(	(	PUNCT
aji-30	159	34	pvalue=0.0001	pvalue=0.0001	NOUN
aji-30	159	35	)	)	PUNCT
aji-30	159	36	.	.	PUNCT
aji-30	160	1	4	4	X
aji-30	160	2	.	.	X
aji-30	160	3	discussion	discussion	NOUN
aji-30	160	4			NOUN
aji-30	161	1	we	we	PRON
aji-30	161	2	founded	found	VERB
aji-30	161	3	that	that	DET
aji-30	161	4	disease	disease	NOUN
aji-30	161	5	duration	duration	NOUN
aji-30	161	6	,	,	PUNCT
aji-30	161	7	dmard	dmard	ADJ
aji-30	161	8	naïve	naïve	ADJ
aji-30	161	9	period	period	NOUN
aji-30	161	10	,	,	PUNCT
aji-30	161	11	rf	rf	NOUN
aji-30	161	12	titers	titer	NOUN
aji-30	161	13	,	,	PUNCT
aji-30	161	14	and	and	CCONJ
aji-30	161	15	acpa	acpa	PROPN
aji-30	161	16	titers	titer	NOUN
aji-30	161	17	were	be	AUX
aji-30	161	18	significantly	significantly	ADV
aji-30	161	19	higher	high	ADJ
aji-30	161	20	in	in	ADP
aji-30	161	21	patients	patient	NOUN
aji-30	161	22	with	with	ADP
aji-30	161	23	erosive	erosive	ADJ
aji-30	161	24	disease	disease	NOUN
aji-30	161	25	compared	compare	VERB
aji-30	161	26	with	with	ADP
aji-30	161	27	nonerosive	nonerosive	ADJ
aji-30	161	28	disease	disease	NOUN
aji-30	161	29	(	(	PUNCT
aji-30	161	30	table	table	NOUN
aji-30	161	31	1	1	NUM
aji-30	161	32	)	)	PUNCT
aji-30	161	33	.	.	PUNCT
aji-30	162	1	the	the	DET
aji-30	162	2	most	most	ADV
aji-30	162	3	significant	significant	ADJ
aji-30	162	4	and	and	CCONJ
aji-30	162	5	important	important	ADJ
aji-30	162	6	factor	factor	NOUN
aji-30	162	7	of	of	ADP
aji-30	162	8	them	they	PRON
aji-30	162	9	all	all	PRON
aji-30	162	10	was	be	AUX
aji-30	162	11	acpa	acpa	PROPN
aji-30	162	12	titers	titer	NOUN
aji-30	162	13	(	(	PUNCT
aji-30	162	14	p=0.001	p=0.001	NUM
aji-30	162	15	)	)	PUNCT
aji-30	162	16	.	.	PUNCT
aji-30	163	1	this	this	DET
aji-30	163	2	result	result	NOUN
aji-30	163	3	compatible	compatible	ADJ
aji-30	163	4	with	with	ADP
aji-30	163	5	the	the	DET
aji-30	163	6	study	study	NOUN
aji-30	163	7	that	that	PRON
aji-30	163	8	was	be	AUX
aji-30	163	9	done	do	VERB
aji-30	163	10	by	by	ADP
aji-30	163	11	shankar	shankar	PROPN
aji-30	163	12	et	et	PROPN
aji-30	163	13	al	al	PROPN
aji-30	164	1	[	[	X
aji-30	164	2	9	9	NUM
aji-30	164	3	]	]	PUNCT
aji-30	164	4	.	.	PUNCT
aji-30	165	1			PUNCT
aji-30	165	2	the	the	DET
aji-30	165	3	long	long	ADJ
aji-30	165	4	duration	duration	NOUN
aji-30	165	5	without	without	ADP
aji-30	165	6	compatible	compatible	ADJ
aji-30	165	7	treatment	treatment	NOUN
aji-30	165	8	with	with	ADP
aji-30	165	9	dmards	dmard	NOUN
aji-30	165	10	can	can	AUX
aji-30	165	11	be	be	AUX
aji-30	165	12	attributed	attribute	VERB
aji-30	165	13	in	in	ADP
aji-30	165	14	syria	syria	PROPN
aji-30	165	15	to	to	ADP
aji-30	165	16	the	the	DET
aji-30	165	17	lack	lack	NOUN
aji-30	165	18	of	of	ADP
aji-30	165	19	medications	medication	NOUN
aji-30	165	20	in	in	ADP
aji-30	165	21	the	the	DET
aji-30	165	22	light	light	NOUN
aji-30	165	23	of	of	ADP
aji-30	165	24	the	the	DET
aji-30	165	25	economic	economic	ADJ
aji-30	165	26	situation	situation	NOUN
aji-30	165	27	.	.	PUNCT
aji-30	166	1			X
aji-30	166	2	the	the	DET
aji-30	166	3	most	most	ADV
aji-30	166	4	significant	significant	ADJ
aji-30	166	5	difference	difference	NOUN
aji-30	166	6	was	be	AUX
aji-30	166	7	in	in	ADP
aji-30	166	8	acpa	acpa	NOUN
aji-30	166	9	,	,	PUNCT
aji-30	166	10	rf	rf	PROPN
aji-30	166	11	titers	titer	NOUN
aji-30	166	12	between	between	ADP
aji-30	166	13	patients	patient	NOUN
aji-30	166	14	with	with	ADP
aji-30	166	15	erosive	erosive	NOUN
aji-30	166	16	and	and	CCONJ
aji-30	166	17	non	non	ADJ
aji-30	166	18	-	-	ADJ
aji-30	166	19	erosive	erosive	ADJ
aji-30	166	20	disease	disease	NOUN
aji-30	166	21	,	,	PUNCT
aji-30	166	22	what	what	PRON
aji-30	166	23	confirms	confirm	VERB
aji-30	166	24	that	that	SCONJ
aji-30	166	25	the	the	DET
aji-30	166	26	combination	combination	NOUN
aji-30	166	27	of	of	ADP
aji-30	166	28	acpa	acpa	PRON
aji-30	166	29	and	and	CCONJ
aji-30	166	30	rf	rf	PRON
aji-30	166	31	are	be	AUX
aji-30	166	32	associated	associate	VERB
aji-30	166	33	with	with	ADP
aji-30	166	34	more	more	ADV
aji-30	166	35	aggressive	aggressive	ADJ
aji-30	166	36	articular	articular	ADJ
aji-30	166	37	disease	disease	NOUN
aji-30	166	38	and	and	CCONJ
aji-30	166	39	that	that	SCONJ
aji-30	166	40	the	the	DET
aji-30	166	41	association	association	NOUN
aji-30	166	42	of	of	ADP
aji-30	166	43	both	both	DET
aji-30	166	44	rf	rf	NOUN
aji-30	166	45	and	and	CCONJ
aji-30	166	46	acpa	acpa	PRON
aji-30	166	47	is	be	AUX
aji-30	166	48	independent	independent	ADJ
aji-30	166	49	factor	factor	NOUN
aji-30	166	50	for	for	ADP
aji-30	166	51	more	more	ADV
aji-30	166	52	severe	severe	ADJ
aji-30	166	53	destructive	destructive	ADJ
aji-30	166	54	disease	disease	NOUN
aji-30	167	1	[	[	X
aji-30	167	2	10,1,6	10,1,6	NOUN
aji-30	167	3	]	]	PUNCT
aji-30	167	4	.	.	PUNCT
aji-30	168	1			X
aji-30	168	2	the	the	DET
aji-30	168	3	high	high	ADJ
aji-30	168	4	positive	positive	ADJ
aji-30	168	5	correlation	correlation	NOUN
aji-30	168	6	between	between	ADP
aji-30	168	7	acpa	acpa	NOUN
aji-30	168	8	titers	titer	NOUN
aji-30	168	9	and	and	CCONJ
aji-30	168	10	sharp	sharp	ADJ
aji-30	168	11	scores	score	NOUN
aji-30	168	12	(	(	PUNCT
aji-30	168	13	r=0.7	r=0.7	NOUN
aji-30	168	14	,	,	PUNCT
aji-30	168	15	p=0.0001	p=0.0001	PROPN
aji-30	168	16	)	)	PUNCT
aji-30	168	17	(	(	PUNCT
aji-30	168	18	fig	fig	NOUN
aji-30	168	19	.	.	PUNCT
aji-30	168	20	2	2	NUM
aji-30	168	21	)	)	PUNCT
aji-30	168	22	indicates	indicate	VERB
aji-30	168	23	that	that	SCONJ
aji-30	168	24	acpa	acpa	PRON
aji-30	168	25	has	have	VERB
aji-30	168	26	a	a	DET
aji-30	168	27	significant	significant	ADJ
aji-30	168	28	role	role	NOUN
aji-30	168	29	in	in	ADP
aji-30	168	30	predicting	predict	VERB
aji-30	168	31	the	the	DET
aji-30	168	32	radiographic	radiographic	ADJ
aji-30	168	33	and	and	CCONJ
aji-30	168	34	structural	structural	ADJ
aji-30	168	35	damage	damage	NOUN
aji-30	168	36	in	in	ADP
aji-30	168	37	rheumatoid	rheumatoid	NOUN
aji-30	168	38	patients	patient	NOUN
aji-30	168	39	,	,	PUNCT
aji-30	168	40	and	and	CCONJ
aji-30	168	41	that	that	PRON
aji-30	168	42	corresponds	correspond	VERB
aji-30	168	43	with	with	ADP
aji-30	168	44	a	a	DET
aji-30	168	45	previous	previous	ADJ
aji-30	168	46	study	study	NOUN
aji-30	168	47	by	by	ADP
aji-30	168	48	meyer	meyer	PROPN
aji-30	168	49	et	et	PROPN
aji-30	168	50	al	al	PROPN
aji-30	168	51	.	.	PUNCT
aji-30	169	1	that	that	PRON
aji-30	169	2	included	include	VERB
aji-30	169	3	191	191	NUM
aji-30	169	4	patients	patient	NOUN
aji-30	169	5	with	with	ADP
aji-30	169	6	recent	recent	ADJ
aji-30	169	7	oncet	oncet	PROPN
aji-30	169	8	ra	ra	PROPN
aji-30	169	9	followed	follow	VERB
aji-30	169	10	for	for	ADP
aji-30	169	11	5	5	NUM
aji-30	169	12	years	year	NOUN
aji-30	169	13	.	.	PUNCT
aji-30	170	1	their	their	PRON
aji-30	170	2	serum	serum	NOUN
aji-30	170	3	samples	sample	NOUN
aji-30	170	4	were	be	AUX
aji-30	170	5	examined	examine	VERB
aji-30	170	6	for	for	ADP
aji-30	170	7	acpa	acpa	NOUN
aji-30	170	8	,	,	PUNCT
aji-30	170	9	and	and	CCONJ
aji-30	170	10	erosions	erosion	NOUN
aji-30	170	11	female	female	ADJ
aji-30	170	12	83	83	NUM
aji-30	170	13	%	%	NOUN
aji-30	170	14	male	male	ADJ
aji-30	170	15	17	17	NUM
aji-30	170	16	%	%	NOUN
aji-30	170	17	distribution	distribution	NOUN
aji-30	170	18	of	of	ADP
aji-30	170	19	patients	patient	NOUN
aji-30	170	20	according	accord	VERB
aji-30	170	21	to	to	ADP
aji-30	170	22	sex	sex	NOUN
aji-30	170	23	sex	sex	NOUN
aji-30	170	24	ratio(f	ratio(f	NOUN
aji-30	170	25	:	:	PUNCT
aji-30	170	26	m)=4.9:1	m)=4.9:1	ADJ
aji-30	170	27	female	female	ADJ
aji-30	170	28	male	male	NOUN
aji-30	170	29	jnad	jnad	NOUN
aji-30	170	30	et	et	PROPN
aji-30	170	31	al	al	PROPN
aji-30	170	32	.	.	PROPN
aji-30	170	33	;	;	PUNCT
aji-30	170	34	aji	aji	PROPN
aji-30	170	35	,	,	PUNCT
aji-30	170	36	3(1	3(1	NUM
aji-30	170	37	):	):	PUNCT
aji-30	170	38	305	305	NUM
aji-30	170	39	-	-	SYM
aji-30	170	40	310	310	NUM
aji-30	170	41	,	,	PUNCT
aji-30	170	42	2020	2020	NUM
aji-30	170	43	;	;	PUNCT
aji-30	170	44	article	article	NOUN
aji-30	170	45	no.aji.61363	no.aji.61363	NOUN
aji-30	170	46	308	308	NUM
aji-30	170	47	were	be	AUX
aji-30	170	48	scored	score	VERB
aji-30	170	49	using	use	VERB
aji-30	170	50	sharp	sharp	ADJ
aji-30	170	51	scores	score	NOUN
aji-30	170	52	modified	modify	VERB
aji-30	170	53	as	as	SCONJ
aji-30	170	54	described	describe	VERB
aji-30	170	55	by	by	ADP
aji-30	170	56	van	van	PROPN
aji-30	170	57	der	der	ADJ
aji-30	170	58	heijde	heijde	NOUN
aji-30	170	59	.	.	PUNCT
aji-30	171	1	their	their	PRON
aji-30	171	2	results	result	NOUN
aji-30	171	3	suggested	suggest	VERB
aji-30	171	4	that	that	SCONJ
aji-30	171	5	odds	odd	NOUN
aji-30	171	6	of	of	ADP
aji-30	171	7	a	a	DET
aji-30	171	8	complete	complete	ADJ
aji-30	171	9	sharp	sharp	ADJ
aji-30	171	10	score	score	NOUN
aji-30	171	11	increase	increase	NOUN
aji-30	171	12	after	after	ADP
aji-30	171	13	5	5	NUM
aji-30	171	14	years	year	NOUN
aji-30	171	15	was	be	AUX
aji-30	171	16	significantly	significantly	ADV
aji-30	171	17	higher	high	ADJ
aji-30	171	18	in	in	ADP
aji-30	171	19	patients	patient	NOUN
aji-30	171	20	with	with	ADP
aji-30	171	21	acpa	acpa	PRON
aji-30	171	22	[	[	X
aji-30	171	23	11	11	NUM
aji-30	171	24	]	]	PUNCT
aji-30	171	25	.	.	PUNCT
aji-30	172	1			PUNCT
aji-30	172	2	it	it	PRON
aji-30	172	3	confirms	confirm	VERB
aji-30	172	4	that	that	SCONJ
aji-30	172	5	patients	patient	NOUN
aji-30	172	6	with	with	ADP
aji-30	172	7	erosive	erosive	ADJ
aji-30	172	8	disease	disease	NOUN
aji-30	172	9	had	have	VERB
aji-30	172	10	significantly	significantly	ADV
aji-30	172	11	higher	high	ADJ
aji-30	172	12	acpa	acpa	NOUN
aji-30	172	13	titers	titer	NOUN
aji-30	172	14	than	than	ADP
aji-30	172	15	those	those	PRON
aji-30	172	16	with	with	ADP
aji-30	172	17	non	non	ADJ
aji-30	172	18	-	-	ADJ
aji-30	172	19	erosive	erosive	ADJ
aji-30	172	20	disease	disease	NOUN
aji-30	172	21	;	;	PUNCT
aji-30	172	22	consequently	consequently	ADV
aji-30	172	23	,	,	PUNCT
aji-30	172	24	high	high	ADJ
aji-30	172	25	titers	titer	NOUN
aji-30	172	26	of	of	ADP
aji-30	172	27	acpa	acpa	PROPN
aji-30	172	28	antibodies	antibodie	VERB
aji-30	172	29	are	be	AUX
aji-30	172	30	associated	associate	VERB
aji-30	172	31	with	with	ADP
aji-30	172	32	more	more	ADV
aji-30	172	33	aggressive	aggressive	ADJ
aji-30	172	34	disease	disease	NOUN
aji-30	172	35	,	,	PUNCT
aji-30	172	36	as	as	SCONJ
aji-30	172	37	measured	measure	VERB
aji-30	172	38	by	by	ADP
aji-30	172	39	significantly	significantly	ADV
aji-30	172	40	higher	high	ADJ
aji-30	172	41	sharp	sharp	ADJ
aji-30	172	42	scores[6	scores[6	ADV
aji-30	172	43	]	]	PUNCT
aji-30	172	44	.	.	PUNCT
aji-30	173	1			PUNCT
aji-30	173	2	finally	finally	ADV
aji-30	173	3	,	,	PUNCT
aji-30	173	4	this	this	DET
aji-30	173	5	study	study	NOUN
aji-30	173	6	showed	show	VERB
aji-30	173	7	the	the	DET
aji-30	173	8	effect	effect	NOUN
aji-30	173	9	of	of	ADP
aji-30	173	10	dmard	dmard	ADJ
aji-30	173	11	naïve	naïve	ADJ
aji-30	173	12	period	period	NOUN
aji-30	173	13	and	and	CCONJ
aji-30	173	14	the	the	DET
aji-30	173	15	disease	disease	NOUN
aji-30	173	16	duration	duration	NOUN
aji-30	173	17	on	on	ADP
aji-30	173	18	erosion	erosion	NOUN
aji-30	173	19	formation	formation	NOUN
aji-30	173	20	,	,	PUNCT
aji-30	173	21	as	as	SCONJ
aji-30	173	22	the	the	DET
aji-30	173	23	median	median	NOUN
aji-30	173	24	of	of	ADP
aji-30	173	25	dmard	dmard	ADJ
aji-30	173	26	naïve	naïve	ADJ
aji-30	173	27	period	period	NOUN
aji-30	173	28	and	and	CCONJ
aji-30	173	29	the	the	DET
aji-30	173	30	median	median	ADJ
aji-30	173	31	disease	disease	NOUN
aji-30	173	32	duration	duration	NOUN
aji-30	173	33	were	be	AUX
aji-30	173	34	significantly	significantly	ADV
aji-30	173	35	higher	high	ADJ
aji-30	173	36	in	in	ADP
aji-30	173	37	patients	patient	NOUN
aji-30	173	38	with	with	ADP
aji-30	173	39	erosive	erosive	ADJ
aji-30	173	40	disease	disease	NOUN
aji-30	173	41	compared	compare	VERB
aji-30	173	42	to	to	ADP
aji-30	173	43	patients	patient	NOUN
aji-30	173	44	with	with	ADP
aji-30	173	45	non	non	ADJ
aji-30	173	46	-	-	ADJ
aji-30	173	47	erosive	erosive	ADJ
aji-30	173	48	disease	disease	NOUN
aji-30	174	1	[	[	X
aji-30	174	2	12	12	NUM
aji-30	174	3	]	]	PUNCT
aji-30	174	4	.	.	PUNCT
aji-30	175	1	table	table	NOUN
aji-30	175	2	1	1	NUM
aji-30	175	3	.	.	PUNCT
aji-30	176	1	characteristics	characteristic	NOUN
aji-30	176	2	of	of	ADP
aji-30	176	3	patients	patient	NOUN
aji-30	176	4	with	with	ADP
aji-30	176	5	erosive	erosive	NOUN
aji-30	176	6	and	and	CCONJ
aji-30	176	7	non	non	ADJ
aji-30	176	8	-	-	ADJ
aji-30	176	9	erosive	erosive	ADJ
aji-30	176	10	disease	disease	NOUN
aji-30	176	11	characteristics	characteristic	NOUN
aji-30	176	12	erosive	erosive	VERB
aji-30	176	13	disease(n=44	disease(n=44	PROPN
aji-30	176	14	)	)	PUNCT
aji-30	176	15	non	non	NOUN
aji-30	176	16	erosive	erosive	ADJ
aji-30	176	17	disease(n=10	disease(n=10	PROPN
aji-30	176	18	)	)	PUNCT
aji-30	176	19	test	test	NOUN
aji-30	176	20	used	use	VERB
aji-30	176	21	pvalue	pvalue	VERB
aji-30	176	22	the	the	DET
aji-30	176	23	statistical	statistical	ADJ
aji-30	176	24	significance	significance	NOUN
aji-30	176	25	disease	disease	NOUN
aji-30	176	26	duration	duration	NOUN
aji-30	176	27	(	(	PUNCT
aji-30	176	28	yr	yr	NOUN
aji-30	176	29	)	)	PUNCT
aji-30	176	30	median	median	NOUN
aji-30	176	31	(	(	PUNCT
aji-30	176	32	iqr	iqr	NOUN
aji-30	176	33	)	)	PUNCT
aji-30	176	34	3.5	3.5	NUM
aji-30	176	35	(	(	PUNCT
aji-30	176	36	1	1	NUM
aji-30	176	37	-	-	SYM
aji-30	176	38	20	20	NUM
aji-30	176	39	)	)	PUNCT
aji-30	176	40	2	2	NUM
aji-30	176	41	(	(	PUNCT
aji-30	176	42	1	1	NUM
aji-30	176	43	-	-	SYM
aji-30	176	44	3	3	NUM
aji-30	176	45	)	)	PUNCT
aji-30	176	46	mann	mann	PROPN
aji-30	176	47	whitney	whitney	PROPN
aji-30	176	48	0.03	0.03	NUM
aji-30	176	49	s	s	PART
aji-30	176	50	dmard	dmard	ADJ
aji-30	176	51	naïve	naïve	ADJ
aji-30	176	52	period	period	NOUN
aji-30	176	53	(	(	PUNCT
aji-30	176	54	month	month	NOUN
aji-30	176	55	)	)	PUNCT
aji-30	176	56	median	median	NOUN
aji-30	176	57	(	(	PUNCT
aji-30	176	58	iqr	iqr	NOUN
aji-30	176	59	)	)	PUNCT
aji-30	176	60	12	12	NUM
aji-30	176	61	(	(	PUNCT
aji-30	176	62	0	0	NUM
aji-30	176	63	-	-	SYM
aji-30	176	64	60	60	NUM
aji-30	176	65	)	)	PUNCT
aji-30	176	66	10.5	10.5	NUM
aji-30	176	67	(	(	PUNCT
aji-30	176	68	0	0	NUM
aji-30	176	69	-	-	SYM
aji-30	176	70	24	24	NUM
aji-30	176	71	)	)	PUNCT
aji-30	176	72	mann	mann	PROPN
aji-30	176	73	whitney	whitney	PROPN
aji-30	176	74	0.04	0.04	NUM
aji-30	176	75	s	s	PART
aji-30	176	76	rf	rf	NOUN
aji-30	176	77	positivity	positivity	NOUN
aji-30	176	78	(	(	PUNCT
aji-30	176	79	%	%	INTJ
aji-30	176	80	)	)	PUNCT
aji-30	176	81	31	31	NUM
aji-30	176	82	(	(	PUNCT
aji-30	176	83	70.45	70.45	NUM
aji-30	176	84	)	)	PUNCT
aji-30	176	85	6	6	NUM
aji-30	176	86	(	(	PUNCT
aji-30	176	87	60	60	NUM
aji-30	176	88	)	)	PUNCT
aji-30	176	89	chi	chi	NOUN
aji-30	176	90	-	-	PUNCT
aji-30	176	91	square	square	NOUN
aji-30	176	92	0.07	0.07	NUM
aji-30	177	1	n.s	n.s	PROPN
aji-30	177	2	rf	rf	NOUN
aji-30	177	3	positivity	positivity	NOUN
aji-30	177	4	(	(	PUNCT
aji-30	177	5	u	u	NOUN
aji-30	177	6	/	/	SYM
aji-30	177	7	ml	ml	ADJ
aji-30	177	8	)	)	PUNCT
aji-30	177	9	median	median	NOUN
aji-30	177	10	(	(	PUNCT
aji-30	177	11	iqr	iqr	NOUN
aji-30	177	12	)	)	PUNCT
aji-30	177	13	47	47	NUM
aji-30	177	14	(	(	PUNCT
aji-30	177	15	1	1	NUM
aji-30	177	16	-	-	SYM
aji-30	177	17	192	192	NUM
aji-30	177	18	)	)	PUNCT
aji-30	177	19	30	30	NUM
aji-30	177	20	(	(	PUNCT
aji-30	177	21	10	10	NUM
aji-30	177	22	-	-	SYM
aji-30	177	23	210	210	NUM
aji-30	177	24	)	)	PUNCT
aji-30	177	25	mann	mann	PROPN
aji-30	177	26	whitney	whitney	PROPN
aji-30	177	27	0.002	0.002	NUM
aji-30	177	28	s	s	PART
aji-30	177	29	median	median	ADJ
aji-30	177	30	acpa	acpa	PROPN
aji-30	177	31	titer	titer	NOUN
aji-30	177	32	(	(	PUNCT
aji-30	177	33	u	u	NOUN
aji-30	177	34	/	/	SYM
aji-30	177	35	ml	ml	ADJ
aji-30	177	36	)	)	PUNCT
aji-30	177	37	median	median	NOUN
aji-30	177	38	(	(	PUNCT
aji-30	177	39	iqr	iqr	NOUN
aji-30	177	40	)	)	PUNCT
aji-30	177	41	16.2	16.2	NUM
aji-30	177	42	(	(	PUNCT
aji-30	177	43	5.1	5.1	NUM
aji-30	177	44	-	-	SYM
aji-30	177	45	300	300	NUM
aji-30	177	46	)	)	PUNCT
aji-30	177	47	7.5	7.5	NUM
aji-30	177	48	(	(	PUNCT
aji-30	177	49	5.4	5.4	NUM
aji-30	177	50	-	-	SYM
aji-30	177	51	38	38	NUM
aji-30	177	52	)	)	PUNCT
aji-30	177	53	mann	mann	PROPN
aji-30	177	54	whitney	whitney	PROPN
aji-30	177	55	0.001	0.001	NUM
aji-30	177	56	s	s	PART
aji-30	177	57	dmard	dmard	NOUN
aji-30	177	58	:	:	PUNCT
aji-30	177	59	disease	disease	NOUN
aji-30	177	60	modifying	modify	VERB
aji-30	177	61	anti	anti	ADJ
aji-30	177	62	rheumatic	rheumatic	ADJ
aji-30	177	63	drugs	drug	NOUN
aji-30	177	64	acpa	acpa	VERB
aji-30	177	65	:	:	PUNCT
aji-30	177	66	anti	anti	ADJ
aji-30	177	67	citrullinated	citrullinate	VERB
aji-30	177	68	peptides	peptide	NOUN
aji-30	177	69	antibody	antibody	NOUN
aji-30	177	70	s	s	PART
aji-30	177	71	:	:	PUNCT
aji-30	177	72	statistically	statistically	ADV
aji-30	177	73	significant	significant	ADJ
aji-30	177	74	n.s	n.s	PROPN
aji-30	177	75	:	:	PUNCT
aji-30	177	76	statistically	statistically	ADV
aji-30	177	77	not	not	PART
aji-30	177	78	significant	significant	ADJ
aji-30	177	79	fig	fig	NOUN
aji-30	177	80	.	.	PUNCT
aji-30	178	1	2	2	X
aji-30	178	2	.	.	X
aji-30	178	3	showing	show	VERB
aji-30	178	4	high	high	ADJ
aji-30	178	5	positive	positive	ADJ
aji-30	178	6	correlation	correlation	NOUN
aji-30	178	7	between	between	ADP
aji-30	178	8	acpa	acpa	PROPN
aji-30	178	9	titers	titer	NOUN
aji-30	178	10	and	and	CCONJ
aji-30	178	11	sharp	sharp	ADJ
aji-30	178	12	scores	score	NOUN
aji-30	178	13	.	.	PUNCT
aji-30	179	1	r=0.7	r=0.7	NOUN
aji-30	179	2	,	,	PUNCT
aji-30	179	3	p=0.0001	p=0.0001	NOUN
aji-30	179	4	0	0	NUM
aji-30	179	5	50	50	NUM
aji-30	179	6	100	100	NUM
aji-30	179	7	150	150	NUM
aji-30	179	8	200	200	NUM
aji-30	179	9	250	250	NUM
aji-30	179	10	300	300	NUM
aji-30	179	11	350	350	NUM
aji-30	179	12	400	400	NUM
aji-30	179	13	0	0	NUM
aji-30	179	14	50	50	NUM
aji-30	179	15	100	100	NUM
aji-30	179	16	150	150	NUM
aji-30	179	17	200	200	NUM
aji-30	179	18	250	250	NUM
aji-30	179	19	300	300	NUM
aji-30	179	20	350	350	NUM
aji-30	179	21	sh	sh	INTJ
aji-30	179	22	a	a	DET
aji-30	179	23	r	r	NOUN
aji-30	179	24	p	p	X
aji-30	179	25	acpa	acpa	PROPN
aji-30	179	26	u	u	NOUN
aji-30	179	27	/	/	SYM
aji-30	179	28	ml	ml	ADP
aji-30	179	29	sharp	sharp	ADJ
aji-30	179	30	jnad	jnad	NOUN
aji-30	179	31	et	et	PROPN
aji-30	179	32	al	al	PROPN
aji-30	179	33	.	.	PROPN
aji-30	179	34	;	;	PUNCT
aji-30	179	35	aji	aji	PROPN
aji-30	179	36	,	,	PUNCT
aji-30	179	37	3(1	3(1	NUM
aji-30	179	38	):	):	PUNCT
aji-30	179	39	305	305	NUM
aji-30	179	40	-	-	SYM
aji-30	179	41	310	310	NUM
aji-30	179	42	,	,	PUNCT
aji-30	179	43	2020	2020	NUM
aji-30	179	44	;	;	PUNCT
aji-30	179	45	article	article	NOUN
aji-30	179	46	no.aji.61363	no.aji.61363	VERB
aji-30	179	47	309	309	NUM
aji-30	179	48	5	5	NUM
aji-30	179	49	.	.	PUNCT
aji-30	180	1	conclusion	conclusion	NOUN
aji-30	180	2			NOUN
aji-30	180	3	acpa	acpa	PROPN
aji-30	180	4	titers	titer	NOUN
aji-30	180	5	are	be	AUX
aji-30	180	6	reliable	reliable	ADJ
aji-30	180	7	predictors	predictor	NOUN
aji-30	180	8	of	of	ADP
aji-30	180	9	erosive	erosive	ADJ
aji-30	180	10	disease	disease	NOUN
aji-30	180	11	,	,	PUNCT
aji-30	180	12	in	in	ADP
aji-30	180	13	addition	addition	NOUN
aji-30	180	14	to	to	ADP
aji-30	180	15	the	the	DET
aji-30	180	16	fact	fact	NOUN
aji-30	180	17	of	of	ADP
aji-30	180	18	their	their	PRON
aji-30	180	19	ability	ability	NOUN
aji-30	180	20	to	to	PART
aji-30	180	21	predict	predict	VERB
aji-30	180	22	the	the	DET
aji-30	180	23	cumulative	cumulative	ADJ
aji-30	180	24	structural	structural	ADJ
aji-30	180	25	and	and	CCONJ
aji-30	180	26	radiological	radiological	ADJ
aji-30	180	27	damage	damage	NOUN
aji-30	180	28	is	be	AUX
aji-30	180	29	superior	superior	ADJ
aji-30	180	30	to	to	ADP
aji-30	180	31	rf	rf	VERB
aji-30	180	32	[	[	X
aji-30	180	33	6,13	6,13	NUM
aji-30	180	34	]	]	PUNCT
aji-30	180	35	.	.	PUNCT
aji-30	181	1			PRON
aji-30	181	2	acpa	acpa	PROPN
aji-30	181	3	is	be	AUX
aji-30	181	4	very	very	ADV
aji-30	181	5	important	important	ADJ
aji-30	181	6	serological	serological	ADJ
aji-30	181	7	marker	marker	NOUN
aji-30	181	8	in	in	ADP
aji-30	181	9	identifying	identify	VERB
aji-30	181	10	patients	patient	NOUN
aji-30	181	11	with	with	ADP
aji-30	181	12	worse	bad	ADJ
aji-30	181	13	prognosis	prognosis	NOUN
aji-30	181	14	who	who	PRON
aji-30	181	15	may	may	AUX
aji-30	181	16	develop	develop	VERB
aji-30	181	17	more	more	ADV
aji-30	181	18	severe	severe	ADJ
aji-30	181	19	structural	structural	ADJ
aji-30	181	20	damage	damage	NOUN
aji-30	181	21	,	,	PUNCT
aji-30	181	22	and	and	CCONJ
aji-30	181	23	need	need	VERB
aji-30	181	24	early	early	ADJ
aji-30	181	25	aggressive	aggressive	ADJ
aji-30	181	26	treatment	treatment	NOUN
aji-30	181	27	and	and	CCONJ
aji-30	181	28	consequently	consequently	ADV
aji-30	181	29	improves	improve	VERB
aji-30	181	30	their	their	PRON
aji-30	181	31	clinical	clinical	ADJ
aji-30	181	32	outcome	outcome	NOUN
aji-30	181	33	and	and	CCONJ
aji-30	181	34	reduce	reduce	VERB
aji-30	181	35	joint	joint	ADJ
aji-30	181	36	damage	damage	NOUN
aji-30	181	37	and	and	CCONJ
aji-30	181	38	disability[14	disability[14	PROPN
aji-30	181	39	]	]	PUNCT
aji-30	181	40	.	.	PUNCT
aji-30	182	1			NOUN
aji-30	182	2	determination	determination	NOUN
aji-30	182	3	of	of	ADP
aji-30	182	4	acpa	acpa	PRON
aji-30	182	5	are	be	AUX
aji-30	182	6	extremely	extremely	ADV
aji-30	182	7	valuable	valuable	ADJ
aji-30	182	8	marker	marker	NOUN
aji-30	182	9	which	which	PRON
aji-30	182	10	is	be	AUX
aji-30	182	11	especially	especially	ADV
aji-30	182	12	useful	useful	ADJ
aji-30	182	13	in	in	ADP
aji-30	182	14	rf	rf	PRON
aji-30	182	15	negative	negative	ADJ
aji-30	182	16	patients	patient	NOUN
aji-30	182	17	with	with	ADP
aji-30	182	18	early	early	ADJ
aji-30	182	19	arthritis	arthritis	NOUN
aji-30	182	20	who	who	PRON
aji-30	182	21	did	do	AUX
aji-30	182	22	not	not	PART
aji-30	182	23	yet	yet	ADV
aji-30	182	24	fulfill	fulfill	VERB
aji-30	182	25	the	the	DET
aji-30	182	26	diagnostic	diagnostic	ADJ
aji-30	182	27	criteria	criterion	NOUN
aji-30	182	28	of	of	ADP
aji-30	182	29	ra	ra	PROPN
aji-30	183	1	[	[	X
aji-30	183	2	1,14	1,14	X
aji-30	183	3	]	]	PUNCT
aji-30	183	4	.	.	PUNCT
aji-30	184	1	consent	consent	NOUN
aji-30	184	2	and	and	CCONJ
aji-30	184	3	ethical	ethical	ADJ
aji-30	184	4	approval	approval	NOUN
aji-30	184	5	this	this	DET
aji-30	184	6	study	study	NOUN
aji-30	184	7	was	be	AUX
aji-30	184	8	reviewed	review	VERB
aji-30	184	9	and	and	CCONJ
aji-30	184	10	approved	approve	VERB
aji-30	184	11	by	by	ADP
aji-30	184	12	the	the	DET
aji-30	184	13	moral	moral	ADJ
aji-30	184	14	committee	committee	NOUN
aji-30	184	15	of	of	ADP
aji-30	184	16	the	the	DET
aji-30	184	17	tishreen	tishreen	PROPN
aji-30	184	18	university	university	NOUN
aji-30	184	19	hospital	hospital	NOUN
aji-30	184	20	.	.	PUNCT
aji-30	185	1	as	as	ADP
aji-30	185	2	per	per	ADP
aji-30	185	3	international	international	ADJ
aji-30	185	4	standard	standard	NOUN
aji-30	185	5	or	or	CCONJ
aji-30	185	6	university	university	NOUN
aji-30	185	7	standard	standard	ADJ
aji-30	185	8	guideline	guideline	PROPN
aji-30	185	9	participant	participant	ADJ
aji-30	185	10	consent	consent	NOUN
aji-30	185	11	has	have	AUX
aji-30	185	12	been	be	AUX
aji-30	185	13	collected	collect	VERB
aji-30	185	14	and	and	CCONJ
aji-30	185	15	preserved	preserve	VERB
aji-30	185	16	by	by	ADP
aji-30	185	17	the	the	DET
aji-30	185	18	authors	author	NOUN
aji-30	185	19	.	.	PUNCT
aji-30	186	1	acknowledgements	acknowledgement	NOUN
aji-30	186	2	we	we	PRON
aji-30	186	3	wish	wish	VERB
aji-30	186	4	to	to	PART
aji-30	186	5	thank	thank	VERB
aji-30	186	6	doctors	doctor	NOUN
aji-30	186	7	and	and	CCONJ
aji-30	186	8	technicians	technician	NOUN
aji-30	186	9	in	in	ADP
aji-30	186	10	laboratory	laboratory	NOUN
aji-30	186	11	and	and	CCONJ
aji-30	186	12	radiology	radiology	NOUN
aji-30	186	13	departments	department	NOUN
aji-30	186	14	of	of	ADP
aji-30	186	15	tishreen	tishreen	PROPN
aji-30	186	16	university	university	NOUN
aji-30	186	17	hospital	hospital	NOUN
aji-30	186	18	who	who	PRON
aji-30	186	19	worked	work	VERB
aji-30	186	20	with	with	ADP
aji-30	186	21	us	we	PRON
aji-30	186	22	.	.	PUNCT
aji-30	187	1	we	we	PRON
aji-30	187	2	would	would	AUX
aji-30	187	3	like	like	VERB
aji-30	187	4	to	to	PART
aji-30	187	5	thank	thank	VERB
aji-30	187	6	miss	miss	PROPN
aji-30	187	7	elissar	elissar	PROPN
aji-30	187	8	hejazia	hejazia	PROPN
aji-30	187	9	,	,	PUNCT
aji-30	187	10	dr	dr	PROPN
aji-30	187	11	.	.	PROPN
aji-30	187	12	leen	leen	PROPN
aji-30	187	13	doya	doya	PROPN
aji-30	187	14	,	,	PUNCT
aji-30	187	15	and	and	CCONJ
aji-30	187	16	dr	dr	PROPN
aji-30	187	17	.	.	PROPN
aji-30	187	18	rawa	rawa	PROPN
aji-30	187	19	saad	saad	PROPN
aji-30	187	20	for	for	ADP
aji-30	187	21	technical	technical	ADJ
aji-30	187	22	help	help	NOUN
aji-30	187	23	.	.	PUNCT
aji-30	188	1	we	we	PRON
aji-30	188	2	would	would	AUX
aji-30	188	3	like	like	VERB
aji-30	188	4	to	to	PART
aji-30	188	5	thank	thank	VERB
aji-30	188	6	the	the	DET
aji-30	188	7	assistance	assistance	NOUN
aji-30	188	8	provided	provide	VERB
aji-30	188	9	by	by	ADP
aji-30	188	10	prof	prof	PROPN
aji-30	188	11	.	.	PUNCT
aji-30	189	1	dr	dr	PROPN
aji-30	189	2	.	.	PROPN
aji-30	189	3	ahmad	ahmad	PROPN
aji-30	189	4	chreitah	chreitah	PROPN
aji-30	189	5	.	.	PUNCT
aji-30	190	1	competing	compete	VERB
aji-30	190	2	interests	interest	NOUN
aji-30	190	3	authors	author	NOUN
aji-30	190	4	have	have	AUX
aji-30	190	5	declared	declare	VERB
aji-30	190	6	that	that	SCONJ
aji-30	190	7	no	no	DET
aji-30	190	8	competing	compete	VERB
aji-30	190	9	interests	interest	NOUN
aji-30	190	10	exist	exist	VERB
aji-30	190	11	.	.	PUNCT
aji-30	191	1	references	reference	NOUN
aji-30	191	2	1	1	NUM
aji-30	191	3	.	.	PUNCT
aji-30	191	4	stainer	stainer	PROPN
aji-30	191	5	g.	g.	PROPN
aji-30	191	6	autoantibodies	autoantibody	NOUN
aji-30	191	7	:	:	PUNCT
aji-30	191	8	diagnostic	diagnostic	ADJ
aji-30	191	9	helpers	helper	NOUN
aji-30	191	10	and	and	CCONJ
aji-30	191	11	pathogenetic	pathogenetic	ADJ
aji-30	191	12	players	player	NOUN
aji-30	191	13	.	.	PUNCT
aji-30	192	1	in	in	ADP
aji-30	192	2	:	:	PUNCT
aji-30	192	3	hochberg	hochberg	PROPN
aji-30	192	4	m	m	PROPN
aji-30	192	5	,	,	PUNCT
aji-30	192	6	silman	silman	PROPN
aji-30	192	7	a	a	PRON
aji-30	192	8	,	,	PUNCT
aji-30	192	9	smolen	smolen	PROPN
aji-30	192	10	j.	j.	PROPN
aji-30	192	11	(	(	PUNCT
aji-30	192	12	eds	eds	PROPN
aji-30	192	13	)	)	PUNCT
aji-30	192	14	rheumatoid	rheumatoid	NOUN
aji-30	192	15	arthritis	arthritis	NOUN
aji-30	192	16	.	.	PUNCT
aji-30	193	1	philadelphia	philadelphia	PROPN
aji-30	193	2	:	:	PUNCT
aji-30	193	3	mosbey	mosbey	VERB
aji-30	193	4	.	.	PUNCT
aji-30	194	1	2008;180	2008;180	X
aji-30	194	2	-	-	SYM
aji-30	194	3	190	190	NUM
aji-30	194	4	.	.	PUNCT
aji-30	195	1	2	2	NUM
aji-30	195	2	.	.	X
aji-30	195	3	weisman	weisman	PROPN
aji-30	195	4	m.	m.	PROPN
aji-30	195	5	definition	definition	NOUN
aji-30	195	6	and	and	CCONJ
aji-30	195	7	classification	classification	NOUN
aji-30	195	8	.	.	PUNCT
aji-30	196	1	rheumatoid	rheumatoid	VERB
aji-30	196	2	arthritis	arthritis	NOUN
aji-30	196	3	.	.	PUNCT
aji-30	197	1	new	new	PROPN
aji-30	197	2	york	york	PROPN
aji-30	197	3	:	:	PUNCT
aji-30	197	4	oxford	oxford	PROPN
aji-30	197	5	university	university	PROPN
aji-30	197	6	press	press	NOUN
aji-30	197	7	.	.	PUNCT
aji-30	198	1	2011;5	2011;5	NUM
aji-30	198	2	-	-	SYM
aji-30	198	3	10	10	NUM
aji-30	198	4	.	.	PUNCT
aji-30	199	1	3	3	X
aji-30	199	2	.	.	X
aji-30	199	3	živkovi	živkovi	PROPN
aji-30	199	4	n	n	PROPN
aji-30	199	5	,	,	PUNCT
aji-30	199	6	stankovi	stankovi	ADJ
aji-30	199	7	a	a	PRON
aji-30	199	8	,	,	PUNCT
aji-30	199	9	krsti	krsti	NOUN
aji-30	199	10	i	i	PRON
aji-30	199	11	,	,	PUNCT
aji-30	199	12	kosti	kosti	PROPN
aji-30	199	13	t	t	PROPN
aji-30	199	14	,	,	PUNCT
aji-30	199	15	ili	ili	PROPN
aji-30	199	16	n.	n.	PROPN
aji-30	199	17	influence	influence	NOUN
aji-30	199	18	of	of	ADP
aji-30	199	19	joint	joint	ADJ
aji-30	199	20	damage	damage	NOUN
aji-30	199	21	on	on	ADP
aji-30	199	22	functional	functional	ADJ
aji-30	199	23	capacities	capacity	NOUN
aji-30	199	24	in	in	ADP
aji-30	199	25	patients	patient	NOUN
aji-30	199	26	suffering	suffer	VERB
aji-30	199	27	from	from	ADP
aji-30	199	28	rheumatoid	rheumatoid	NOUN
aji-30	199	29	arthritis	arthritis	NOUN
aji-30	199	30	.	.	PUNCT
aji-30	200	1	acta	acta	PROPN
aji-30	200	2	med	med	ADJ
aji-30	200	3	media	medium	NOUN
aji-30	200	4	.	.	PUNCT
aji-30	201	1	2009;48(2):18	2009;48(2):18	NUM
aji-30	201	2	-	-	SYM
aji-30	201	3	21	21	NUM
aji-30	201	4	.	.	PUNCT
aji-30	202	1	4	4	NUM
aji-30	202	2	.	.	X
aji-30	202	3	heidari	heidari	PROPN
aji-30	202	4	b.	b.	PROPN
aji-30	202	5	rheumatoid	rheumatoid	PROPN
aji-30	202	6	arthritis	arthritis	NOUN
aji-30	202	7	:	:	PUNCT
aji-30	202	8	early	early	ADJ
aji-30	202	9	diagnosis	diagnosis	NOUN
aji-30	202	10	and	and	CCONJ
aji-30	202	11	treatment	treatment	NOUN
aji-30	202	12	outcomes	outcome	NOUN
aji-30	202	13	.	.	PUNCT
aji-30	203	1	caspian	caspian	PROPN
aji-30	203	2	journal	journal	PROPN
aji-30	203	3	of	of	ADP
aji-30	203	4	internal	internal	ADJ
aji-30	203	5	medicine	medicine	NOUN
aji-30	203	6	.	.	PUNCT
aji-30	204	1	2011;2(1):161	2011;2(1):161	NUM
aji-30	204	2	.	.	NOUN
aji-30	204	3	5	5	NUM
aji-30	204	4	.	.	X
aji-30	204	5	weisman	weisman	PROPN
aji-30	204	6	m.	m.	PROPN
aji-30	204	7	laboratory	laboratory	PROPN
aji-30	204	8	and	and	CCONJ
aji-30	204	9	imaging	imaging	NOUN
aji-30	204	10	assessments	assessment	NOUN
aji-30	204	11	.	.	PUNCT
aji-30	205	1	rheumatoid	rheumatoid	VERB
aji-30	205	2	arthritis	arthritis	NOUN
aji-30	205	3	.	.	PUNCT
aji-30	206	1	new	new	PROPN
aji-30	206	2	york	york	PROPN
aji-30	206	3	:	:	PUNCT
aji-30	206	4	oxford	oxford	PROPN
aji-30	206	5	university	university	PROPN
aji-30	206	6	press	press	NOUN
aji-30	206	7	.	.	PUNCT
aji-30	207	1	2011;55	2011;55	NUM
aji-30	207	2	-	-	SYM
aji-30	207	3	60	60	NUM
aji-30	207	4	6	6	NUM
aji-30	207	5	.	.	PUNCT
aji-30	207	6	song	song	PROPN
aji-30	207	7	yw	yw	PROPN
aji-30	207	8	,	,	PUNCT
aji-30	207	9	kang	kang	PROPN
aji-30	207	10	eh	eh	INTJ
aji-30	207	11	.	.	PUNCT
aji-30	207	12	autoantibodies	autoantibody	NOUN
aji-30	207	13	in	in	ADP
aji-30	207	14	rheumatoid	rheumatoid	NOUN
aji-30	207	15	arthritis	arthritis	NOUN
aji-30	207	16	:	:	PUNCT
aji-30	207	17	rheumatoid	rheumatoid	NOUN
aji-30	207	18	factors	factor	NOUN
aji-30	207	19	and	and	CCONJ
aji-30	207	20	anticitrullinated	anticitrullinate	VERB
aji-30	207	21	protein	protein	NOUN
aji-30	207	22	antibodies	antibodie	VERB
aji-30	207	23	.	.	PUNCT
aji-30	208	1	qjm	qjm	VERB
aji-30	208	2	:	:	PUNCT
aji-30	208	3	an	an	DET
aji-30	208	4	international	international	ADJ
aji-30	208	5	journal	journal	NOUN
aji-30	208	6	of	of	ADP
aji-30	208	7	medicine	medicine	NOUN
aji-30	208	8	.	.	PUNCT
aji-30	209	1	2010;103(3):139	2010;103(3):139	NUM
aji-30	209	2	-	-	SYM
aji-30	209	3	46	46	NUM
aji-30	209	4	.	.	PUNCT
aji-30	210	1	7	7	X
aji-30	210	2	.	.	X
aji-30	210	3	rocha	rocha	PROPN
aji-30	210	4	sd	sd	PROPN
aji-30	210	5	,	,	PUNCT
aji-30	210	6	baldo	baldo	PROPN
aji-30	210	7	dc	dc	PROPN
aji-30	210	8	,	,	PUNCT
aji-30	210	9	andrade	andrade	PROPN
aji-30	210	10	le	le	PROPN
aji-30	210	11	.	.	PROPN
aji-30	211	1	clinical	clinical	ADJ
aji-30	211	2	and	and	CCONJ
aji-30	211	3	pathophysiologic	pathophysiologic	ADJ
aji-30	211	4	relevance	relevance	NOUN
aji-30	211	5	of	of	ADP
aji-30	211	6	autoantibodies	autoantibody	NOUN
aji-30	211	7	in	in	ADP
aji-30	211	8	rheumatoid	rheumatoid	NOUN
aji-30	211	9	arthritis	arthritis	NOUN
aji-30	211	10	.	.	PUNCT
aji-30	212	1	advances	advance	NOUN
aji-30	212	2	in	in	ADP
aji-30	212	3	rheumatology	rheumatology	NOUN
aji-30	212	4	.	.	PUNCT
aji-30	213	1	2019;59	2019;59	X
aji-30	213	2	.	.	NOUN
aji-30	213	3	8	8	NUM
aji-30	213	4	.	.	X
aji-30	214	1	peterfy	peterfy	PROPN
aji-30	214	2	cg	cg	PROPN
aji-30	214	3	,	,	PUNCT
aji-30	214	4	wu	wu	PROPN
aji-30	214	5	c	c	AUX
aji-30	214	6	,	,	PUNCT
aji-30	214	7	lu	lu	PROPN
aji-30	214	8	y	y	PROPN
aji-30	214	9	,	,	PUNCT
aji-30	214	10	genovese	genovese	ADJ
aji-30	214	11	m.	m.	NOUN
aji-30	214	12	comparison	comparison	NOUN
aji-30	214	13	of	of	ADP
aji-30	214	14	the	the	DET
aji-30	214	15	genant	genant	NOUN
aji-30	214	16	-	-	PUNCT
aji-30	214	17	modified	modify	VERB
aji-30	214	18	sharp	sharp	ADJ
aji-30	214	19	and	and	CCONJ
aji-30	214	20	van	van	PROPN
aji-30	214	21	der	der	NOUN
aji-30	214	22	heijde	heijde	NOUN
aji-30	214	23	-	-	PUNCT
aji-30	214	24	modified	modify	VERB
aji-30	214	25	sharp	sharp	ADJ
aji-30	214	26	scoring	scoring	NOUN
aji-30	214	27	methods	method	NOUN
aji-30	214	28	for	for	ADP
aji-30	214	29	radiographic	radiographic	ADJ
aji-30	214	30	assessment	assessment	NOUN
aji-30	214	31	in	in	ADP
aji-30	214	32	rheumatoid	rheumatoid	NOUN
aji-30	214	33	arthritis	arthritis	NOUN
aji-30	214	34	.	.	PUNCT
aji-30	215	1	international	international	ADJ
aji-30	215	2	journal	journal	NOUN
aji-30	215	3	of	of	ADP
aji-30	215	4	clinical	clinical	ADJ
aji-30	215	5	rheumatology	rheumatology	NOUN
aji-30	215	6	.	.	PUNCT
aji-30	216	1	2011;6(1):15	2011;6(1):15	NUM
aji-30	216	2	.	.	NOUN
aji-30	216	3	9	9	NUM
aji-30	216	4	.	.	X
aji-30	217	1	shankar	shankar	PROPN
aji-30	217	2	s	s	PROPN
aji-30	217	3	,	,	PUNCT
aji-30	217	4	grover	grover	PROPN
aji-30	217	5	r	r	PROPN
aji-30	217	6	,	,	PUNCT
aji-30	217	7	handa	handa	PROPN
aji-30	217	8	r.	r.	PROPN
aji-30	217	9	role	role	NOUN
aji-30	217	10	of	of	ADP
aji-30	217	11	anti	anti	ADJ
aji-30	217	12	cyclic	cyclic	ADJ
aji-30	217	13	citrullinated	citrullinate	VERB
aji-30	217	14	peptide	peptide	NOUN
aji-30	217	15	antibodies	antibody	NOUN
aji-30	217	16	in	in	ADP
aji-30	217	17	erosive	erosive	ADJ
aji-30	217	18	disease	disease	NOUN
aji-30	217	19	in	in	ADP
aji-30	217	20	patients	patient	NOUN
aji-30	217	21	with	with	ADP
aji-30	217	22	rheumatoid	rheumatoid	NOUN
aji-30	217	23	arthritis	arthritis	NOUN
aji-30	217	24	.	.	PUNCT
aji-30	218	1	indian	indian	PROPN
aji-30	218	2	journal	journal	PROPN
aji-30	218	3	of	of	ADP
aji-30	218	4	medical	medical	ADJ
aji-30	218	5	research	research	NOUN
aji-30	218	6	.	.	PUNCT
aji-30	219	1	2006;124(6):689	2006;124(6):689	NOUN
aji-30	219	2	-	-	SYM
aji-30	219	3	96	96	NUM
aji-30	219	4	.	.	PUNCT
aji-30	219	5	10	10	NUM
aji-30	219	6	.	.	PUNCT
aji-30	220	1	andrade	andrade	PROPN
aji-30	220	2	f	f	PROPN
aji-30	220	3	,	,	PUNCT
aji-30	220	4	darrah	darrah	PROPN
aji-30	220	5	e	e	PROPN
aji-30	220	6	,	,	PUNCT
aji-30	220	7	rosen	rosen	PROPN
aji-30	220	8	a.	a.	NOUN
aji-30	220	9	autoantibodies	autoantibody	NOUN
aji-30	220	10	in	in	ADP
aji-30	220	11	rheumatoid	rheumatoid	NOUN
aji-30	220	12	arthritis	arthritis	NOUN
aji-30	220	13	.	.	PUNCT
aji-30	221	1	in	in	ADP
aji-30	221	2	:	:	PUNCT
aji-30	221	3	gary	gary	PROPN
aji-30	221	4	s.	s.	PROPN
aji-30	221	5	firestein	firestein	PROPN
aji-30	221	6	,	,	PUNCT
aji-30	221	7	sherine	sherine	PROPN
aji-30	221	8	e.	e.	PROPN
aji-30	221	9	gabriel	gabriel	PROPN
aji-30	221	10	,	,	PUNCT
aji-30	221	11	iain	iain	PROPN
aji-30	221	12	b.	b.	PROPN
aji-30	221	13	mcinnes	mcinnes	PROPN
aji-30	221	14	,	,	PUNCT
aji-30	221	15	james	james	PROPN
aji-30	221	16	r.	r.	PROPN
aji-30	221	17	o’dell	o’dell	PROPN
aji-30	221	18	.	.	PUNCT
aji-30	222	1	(	(	PUNCT
aji-30	222	2	eds	ed	NOUN
aji-30	222	3	)	)	PUNCT
aji-30	222	4	kelley	kelley	NOUN
aji-30	222	5	and	and	CCONJ
aji-30	222	6	firestein	firestein	PROPN
aji-30	222	7	’s	’s	PART
aji-30	222	8	textbook	textbook	NOUN
aji-30	222	9	of	of	ADP
aji-30	222	10	rheumatology	rheumatology	NOUN
aji-30	222	11	,	,	PUNCT
aji-30	222	12	tenth	tenth	ADJ
aji-30	222	13	edition	edition	NOUN
aji-30	222	14	.	.	PUNCT
aji-30	223	1	philadelphia	philadelphia	PROPN
aji-30	223	2	:	:	PUNCT
aji-30	223	3	elsevier	elsevier	NOUN
aji-30	223	4	.	.	PUNCT
aji-30	224	1	2017;831	2017;831	NUM
aji-30	224	2	-	-	SYM
aji-30	224	3	845	845	NUM
aji-30	224	4	.	.	NOUN
aji-30	224	5	11	11	NUM
aji-30	224	6	.	.	PUNCT
aji-30	225	1	vossenaar	vossenaar	PROPN
aji-30	225	2	er	er	INTJ
aji-30	225	3	,	,	PUNCT
aji-30	225	4	van	van	PROPN
aji-30	225	5	venrooij	venrooij	PROPN
aji-30	225	6	wj	wj	PROPN
aji-30	225	7	.	.	PUNCT
aji-30	226	1	anti	anti	ADJ
aji-30	226	2	-	-	ADJ
aji-30	226	3	ccp	ccp	PROPN
aji-30	226	4	antibodies	antibodie	VERB
aji-30	226	5	,	,	PUNCT
aji-30	226	6	a	a	DET
aji-30	226	7	highly	highly	ADV
aji-30	226	8	specific	specific	ADJ
aji-30	226	9	marker	marker	NOUN
aji-30	226	10	for	for	ADP
aji-30	226	11	(	(	PUNCT
aji-30	226	12	early	early	ADJ
aji-30	226	13	)	)	PUNCT
aji-30	226	14	rheumatoid	rheumatoid	NOUN
aji-30	226	15	arthritis	arthritis	NOUN
aji-30	226	16	.	.	PUNCT
aji-30	227	1	clinical	clinical	ADJ
aji-30	227	2	and	and	CCONJ
aji-30	227	3	applied	apply	VERB
aji-30	227	4	immunology	immunology	NOUN
aji-30	227	5	reviews	review	NOUN
aji-30	227	6	.	.	PUNCT
aji-30	228	1	2004;4(4):239	2004;4(4):239	NUM
aji-30	228	2	-	-	SYM
aji-30	228	3	62	62	NUM
aji-30	228	4	.	.	PUNCT
aji-30	229	1	12	12	NUM
aji-30	229	2	.	.	PUNCT
aji-30	230	1	bahadur	bahadur	PROPN
aji-30	230	2	m	m	PROPN
aji-30	230	3	,	,	PUNCT
aji-30	230	4	singh	singh	PROPN
aji-30	230	5	p	p	X
aji-30	230	6	,	,	PUNCT
aji-30	230	7	satyawali	satyawali	PROPN
aji-30	230	8	v	v	PROPN
aji-30	230	9	,	,	PUNCT
aji-30	230	10	joshi	joshi	PROPN
aji-30	230	11	a.	a.	NOUN
aji-30	230	12	role	role	NOUN
aji-30	230	13	of	of	ADP
aji-30	230	14	dmard	dmard	ADJ
aji-30	230	15	naïve	naïve	ADJ
aji-30	230	16	period	period	NOUN
aji-30	230	17	in	in	ADP
aji-30	230	18	the	the	DET
aji-30	230	19	development	development	NOUN
aji-30	230	20	of	of	ADP
aji-30	230	21	severe	severe	ADJ
aji-30	230	22	rheumatoid	rheumatoid	NOUN
aji-30	230	23	arthritis	arthritis	NOUN
aji-30	230	24	.	.	PUNCT
aji-30	231	1	indian	indian	PROPN
aji-30	231	2	journal	journal	PROPN
aji-30	231	3	of	of	ADP
aji-30	231	4	orthopaedics	orthopaedic	NOUN
aji-30	231	5	.	.	PUNCT
aji-30	232	1	2020;1	2020;1	NUM
aji-30	232	2	-	-	SYM
aji-30	232	3	5	5	NUM
aji-30	232	4	.	.	NOUN
aji-30	232	5	13	13	NUM
aji-30	232	6	.	.	PUNCT
aji-30	233	1	jilani	jilani	PROPN
aji-30	233	2	aa	aa	PROPN
aji-30	233	3	,	,	PUNCT
aji-30	233	4	mackworth	mackworth	ADV
aji-30	233	5	-	-	PUNCT
aji-30	233	6	young	young	ADJ
aji-30	233	7	cg	cg	NOUN
aji-30	233	8	.	.	PUNCT
aji-30	234	1	the	the	DET
aji-30	234	2	role	role	NOUN
aji-30	234	3	of	of	ADP
aji-30	234	4	citrullinated	citrullinate	VERB
aji-30	234	5	protein	protein	NOUN
aji-30	234	6	antibodies	antibodie	VERB
aji-30	234	7	in	in	ADP
aji-30	234	8	predicting	predict	VERB
aji-30	234	9	erosive	erosive	ADJ
aji-30	234	10	disease	disease	NOUN
aji-30	234	11	in	in	ADP
aji-30	234	12	rheumatoid	rheumatoid	NOUN
aji-30	234	13	arthritis	arthritis	NOUN
aji-30	234	14	:	:	PUNCT
aji-30	234	15	a	a	DET
aji-30	234	16	systematic	systematic	ADJ
aji-30	234	17	literature	literature	NOUN
aji-30	234	18	review	review	NOUN
aji-30	234	19	and	and	CCONJ
aji-30	234	20	meta	meta	ADJ
aji-30	234	21	-	-	PUNCT
aji-30	234	22	analysis	analysis	NOUN
aji-30	234	23	.	.	PUNCT
aji-30	235	1	international	international	ADJ
aji-30	235	2	journal	journal	PROPN
aji-30	235	3	of	of	ADP
aji-30	235	4	rheumatology	rheumatology	NOUN
aji-30	235	5	;	;	PUNCT
aji-30	235	6	2015	2015	NUM
aji-30	235	7	.	.	PUNCT
aji-30	236	1	jnad	jnad	PROPN
aji-30	236	2	et	et	PROPN
aji-30	236	3	al	al	PROPN
aji-30	236	4	.	.	PROPN
aji-30	236	5	;	;	PUNCT
aji-30	236	6	aji	aji	PROPN
aji-30	236	7	,	,	PUNCT
aji-30	236	8	3(1	3(1	NUM
aji-30	236	9	):	):	PUNCT
aji-30	236	10	305	305	NUM
aji-30	236	11	-	-	SYM
aji-30	236	12	310	310	NUM
aji-30	236	13	,	,	PUNCT
aji-30	236	14	2020	2020	NUM
aji-30	236	15	;	;	PUNCT
aji-30	236	16	article	article	NOUN
aji-30	236	17	no.aji.61363	no.aji.61363	VERB
aji-30	236	18	310	310	NUM
aji-30	236	19	14	14	NUM
aji-30	236	20	.	.	PUNCT
aji-30	237	1	niewold	niewold	PROPN
aji-30	237	2	tb	tb	PROPN
aji-30	237	3	,	,	PUNCT
aji-30	237	4	harrison	harrison	PROPN
aji-30	237	5	mj	mj	PROPN
aji-30	237	6	,	,	PUNCT
aji-30	237	7	paget	paget	PROPN
aji-30	237	8	sa	sa	PROPN
aji-30	237	9	.	.	PUNCT
aji-30	238	1	anti	anti	ADJ
aji-30	238	2	-	-	ADJ
aji-30	238	3	ccp	ccp	ADJ
aji-30	238	4	antibody	antibody	NOUN
aji-30	238	5	testing	testing	NOUN
aji-30	238	6	as	as	ADP
aji-30	238	7	a	a	DET
aji-30	238	8	diagnostic	diagnostic	ADJ
aji-30	238	9	and	and	CCONJ
aji-30	238	10	prognostic	prognostic	ADJ
aji-30	238	11	tool	tool	NOUN
aji-30	238	12	in	in	ADP
aji-30	238	13	rheumatoid	rheumatoid	NOUN
aji-30	238	14	arthritis	arthritis	NOUN
aji-30	238	15	.	.	PUNCT
aji-30	239	1	journal	journal	NOUN
aji-30	239	2	of	of	ADP
aji-30	239	3	the	the	DET
aji-30	239	4	association	association	NOUN
aji-30	239	5	of	of	ADP
aji-30	239	6	physicians	physician	NOUN
aji-30	239	7	.	.	PUNCT
aji-30	240	1	2007;100(4	2007;100(4	X
aji-30	240	2	):	):	PUNCT
aji-30	240	3	193	193	NUM
aji-30	240	4	-	-	SYM
aji-30	240	5	201	201	NUM
aji-30	240	6	.	.	PUNCT
aji-30	241	1	_	_	PUNCT
aji-30	242	1	_	_	PUNCT
aji-30	243	1	_	_	PUNCT
aji-30	244	1	_	_	PUNCT
aji-30	245	1	_	_	PUNCT
aji-30	246	1	_	_	PUNCT
aji-30	247	1	_	_	PUNCT
aji-30	248	1	_	_	PUNCT
aji-30	249	1	_	_	PUNCT
aji-30	250	1	_	_	PUNCT
aji-30	251	1	_	_	PUNCT
aji-30	252	1	_	_	PUNCT
aji-30	253	1	_	_	PUNCT
aji-30	254	1	_	_	PUNCT
aji-30	255	1	_	_	PUNCT
aji-30	256	1	_	_	PUNCT
aji-30	257	1	_	_	PUNCT
aji-30	258	1	_	_	PUNCT
aji-30	259	1	_	_	PUNCT
aji-30	260	1	_	_	PUNCT
aji-30	261	1	_	_	PUNCT
aji-30	262	1	_	_	PUNCT
aji-30	263	1	_	_	PUNCT
aji-30	264	1	_	_	PUNCT
aji-30	265	1	_	_	PUNCT
aji-30	266	1	_	_	PUNCT
aji-30	267	1	_	_	PUNCT
aji-30	268	1	_	_	PUNCT
aji-30	269	1	_	_	PUNCT
aji-30	270	1	_	_	PUNCT
aji-30	271	1	_	_	PUNCT
aji-30	272	1	_	_	PUNCT
aji-30	273	1	_	_	PUNCT
aji-30	274	1	_	_	PUNCT
aji-30	275	1	_	_	PUNCT
aji-30	276	1	_	_	PUNCT
aji-30	277	1	_	_	PUNCT
aji-30	278	1	_	_	PUNCT
aji-30	279	1	_	_	PUNCT
aji-30	280	1	_	_	PUNCT
aji-30	281	1	_	_	PUNCT
aji-30	282	1	_	_	PUNCT
aji-30	283	1	_	_	PUNCT
aji-30	284	1	_	_	PUNCT
aji-30	285	1	_	_	PUNCT
aji-30	286	1	_	_	PUNCT
aji-30	287	1	_	_	PUNCT
aji-30	288	1	_	_	PUNCT
aji-30	289	1	_	_	PUNCT
aji-30	290	1	_	_	PUNCT
aji-30	291	1	_	_	PUNCT
aji-30	292	1	_	_	PUNCT
aji-30	293	1	_	_	PUNCT
aji-30	294	1	_	_	PUNCT
aji-30	295	1	_	_	PUNCT
aji-30	296	1	_	_	PUNCT
aji-30	297	1	_	_	PUNCT
aji-30	298	1	_	_	PUNCT
aji-30	299	1	_	_	PUNCT
aji-30	300	1	_	_	PUNCT
aji-30	301	1	_	_	PUNCT
aji-30	302	1	_	_	PUNCT
aji-30	303	1	_	_	PUNCT
aji-30	304	1	_	_	PUNCT
aji-30	305	1	_	_	PUNCT
aji-30	306	1	_	_	PUNCT
aji-30	307	1	_	_	PUNCT
aji-30	308	1	_	_	PUNCT
aji-30	309	1	_	_	PUNCT
aji-30	310	1	_	_	PUNCT
aji-30	311	1	_	_	PUNCT
aji-30	312	1	_	_	PUNCT
aji-30	313	1	_	_	PUNCT
aji-30	314	1	_	_	PUNCT
aji-30	315	1	_	_	PUNCT
aji-30	316	1	_	_	PUNCT
aji-30	317	1	_	_	PUNCT
aji-30	318	1	_	_	PUNCT
aji-30	319	1	_	_	PUNCT
aji-30	320	1	_	_	PUNCT
aji-30	321	1	_	_	PUNCT
aji-30	322	1	©	©	ADP
aji-30	322	2	2020	2020	NUM
aji-30	322	3	jnad	jnad	NOUN
aji-30	322	4	et	et	PROPN
aji-30	322	5	al	al	PROPN
aji-30	322	6	.	.	PROPN
aji-30	322	7	;	;	PUNCT
aji-30	322	8	this	this	PRON
aji-30	322	9	is	be	AUX
aji-30	322	10	an	an	DET
aji-30	322	11	open	open	ADJ
aji-30	322	12	access	access	NOUN
aji-30	322	13	article	article	NOUN
aji-30	322	14	distributed	distribute	VERB
aji-30	322	15	under	under	ADP
aji-30	322	16	the	the	DET
aji-30	322	17	terms	term	NOUN
aji-30	322	18	of	of	ADP
aji-30	322	19	the	the	DET
aji-30	322	20	creative	creative	ADJ
aji-30	322	21	commons	common	NOUN
aji-30	322	22	attribution	attribution	NOUN
aji-30	322	23	license	license	NOUN
aji-30	322	24	(	(	PUNCT
aji-30	322	25	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-30	322	26	)	)	PUNCT
aji-30	322	27	,	,	PUNCT
aji-30	322	28	which	which	PRON
aji-30	322	29	permits	permit	VERB
aji-30	322	30	unrestricted	unrestricted	ADJ
aji-30	322	31	use	use	NOUN
aji-30	322	32	,	,	PUNCT
aji-30	322	33	distribution	distribution	NOUN
aji-30	322	34	,	,	PUNCT
aji-30	322	35	and	and	CCONJ
aji-30	322	36	reproduction	reproduction	NOUN
aji-30	322	37	in	in	ADP
aji-30	322	38	any	any	DET
aji-30	322	39	medium	medium	NOUN
aji-30	322	40	,	,	PUNCT
aji-30	322	41	provided	provide	VERB
aji-30	322	42	the	the	DET
aji-30	322	43	original	original	ADJ
aji-30	322	44	work	work	NOUN
aji-30	322	45	is	be	AUX
aji-30	322	46	properly	properly	ADV
aji-30	322	47	cited	cite	VERB
aji-30	322	48	.	.	PUNCT
aji-30	323	1	peer	peer	NOUN
aji-30	323	2	-	-	PUNCT
aji-30	323	3	review	review	NOUN
aji-30	323	4	history	history	NOUN
aji-30	323	5	:	:	PUNCT
aji-30	323	6	the	the	DET
aji-30	323	7	peer	peer	NOUN
aji-30	323	8	review	review	NOUN
aji-30	323	9	history	history	NOUN
aji-30	323	10	for	for	ADP
aji-30	323	11	this	this	DET
aji-30	323	12	paper	paper	NOUN
aji-30	323	13	can	can	AUX
aji-30	323	14	be	be	AUX
aji-30	323	15	accessed	access	VERB
aji-30	323	16	here	here	ADV
aji-30	323	17	:	:	PUNCT
aji-30	323	18	http://www.sdiarticle4.com/review-history/61363	http://www.sdiarticle4.com/review-history/61363	VERB
aji-30	323	19	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	X